{"meta":{"schemaVersion":1,"slug":"essential-drugs","sourceDate":"2026-01-29","period":"Gazette dated 29 January 2026 · supplied transcription","refresh":"Gazette revisions only; manual review","sourceHash":"2059a31ef84cf0b0347c18b9fd055c591b51ebe13adc1e64ff93db095038fb78","sourceFiles":["essential-drugs/index.html"]},"categories":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","2. MEDICINES FOR PAIN AND PALLIATIVE CARE","3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS","4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS","5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","6. ANTI-INFECTIVE MEDICINES","7. ANTIMIGRAINE MEDICINES","8. IMMUNOMODULATORS AND ANTINEOPLASTICS","9. MEDICINES AFFECTING THE BLOOD","10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","11. CARDIOVASCULAR MEDICINES","12. DERMATOLOGICAL MEDICINES","13. DIAGNOSTIC AGENTS","14. ANTISEPTICS AND DISINFECTANTS","15. DIURETICS","16. GASTROINTESTINAL MEDICINES","17. MEDICINES FOR ENDOCRINE DISORDERS","18. IMMUNOLOGICALS","19. MUSCLE RELAXANTS (PERIPHERALLY- ACTING) AND CHOLINESTERASE INHIBITORS","20. OPHTHALMOLOGICAL PREPARATIONS","21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","22. PERITONEAL DIALYSIS SOLUTION","23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","24. MEDICINES ACTING ON THE RESPIRATORY TRACT","25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","26. VITAMINS AND MINERALS","27. EAR, NOSE AND THROAT MEDICINES","28. MEDICINES FOR DISEASES OF JOINTS","29. DENTAL MEDICINES AND PREPARATIONS"],"rows":[{"id":1,"name":"Isoflurane","formulations":["Inhalation"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.1 General anaesthetics and oxygen","1.1.1 Inhalational medicines"]},{"id":2,"name":"Nitrous Oxide","formulations":["Inhalation"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.1 General anaesthetics and oxygen","1.1.1 Inhalational medicines"]},{"id":3,"name":"Ketamine","formulations":["Injection: 50 mg/ml"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.1 General anaesthetics and oxygen","1.1.2 Injectable medicines"]},{"id":4,"name":"Thiopental","formulations":["Injection: 10 mg/ml; 20 mg/ml."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.1 General anaesthetics and oxygen","1.1.2 Injectable medicines"]},{"id":5,"name":"Bupivacaine","formulations":["Injection: 0.25%; 0.5%","Injection for spinal anaesthesia: 0.5% / 4 ml ampoule in 7.5% glucose solution."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.2 Local anaesthetics"]},{"id":6,"name":"Ephedrine","formulations":["Injection: 30 mg/ml in ampoule."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.2 Local anaesthetics"]},{"id":7,"name":"Lidocaine","formulations":["Injection: 1%; 2%","Injection for spinal anaesthesia: 5% / 2 ml ampoule in 7.5% glucose solution.","Topical forms: 2% to 4% (hydrochloride)."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.2 Local anaesthetics"]},{"id":8,"name":"Lidocaine + Epinephrine (adrenaline)","formulations":["Injection: 1%; 2% + epinephrine 1:200 000."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.2 Local anaesthetics"]},{"id":9,"name":"Suxamethonium","formulations":["Injection: 50mg/ ml"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.2 Local anaesthetics"]},{"id":10,"name":"Vecuronium","formulations":["Injection: 10mg/vial"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.2 Local anaesthetics"]},{"id":11,"name":"Atropine","formulations":["Injection: 0.6 mg /ml"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.3 Preoperative medication and sedation for short-term procedures"]},{"id":12,"name":"Diazepam","formulations":["Tablet: 10mg","Suppository: 10mg","Injection: 5 mg/ml."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.3 Preoperative medication and sedation for short-term procedures"]},{"id":13,"name":"Midazolam","formulations":["Injection: 1 mg/ml.","Oral liquid: 2 mg/ml","Tablet: 7.5 mg; 15 mg."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.3 Preoperative medication and sedation for short-term procedures"]},{"id":14,"name":"Morphine","formulations":["Injection: 10 mg / ml"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.3 Preoperative medication and sedation for short-term procedures"]},{"id":15,"name":"Pethidine","formulations":["Injection: 50 mg/ml"],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.3 Preoperative medication and sedation for short-term procedures"]},{"id":16,"name":"Oxygen","formulations":["Inhalation","For use in the management of hypoxaemia.","*No more than 30% oxygen should be used to initiate resuscitation of neonates less than or equal to 32 weeks of gestation."],"facilities":"S,T","path":["1. ANAESTHETICS, PREOPERATIVE MEDICINES AND MEDICAL GASES","1.4 Medical Gasses"]},{"id":17,"name":"Acetylsalicylic acid (Aspirin)","formulations":["Tablet: 75 mg"],"facilities":"P,S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)"]},{"id":18,"name":"Diclofenac","formulations":["Injection:75 mg/3 ml","Tablet: 25 mg, 50 mg"],"facilities":"P,S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)"]},{"id":19,"name":"Ibuprofen","formulations":["Oral liquid: 200 mg/5 ml.","Tablet: 200 mg; 400 mg; 600 mg.","*Not in children less than 3 months."],"facilities":"P,S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)"]},{"id":20,"name":"Paracetamol (acetaminophen)","formulations":["Oral liquid: 80mg/ml, 125 mg/5 ml","Suppository: 60mg, 125 mg, 250 mg , 500mg,","Tablet: 500 mg, 665mg, 1000mg","Injection: 10mg/ml"],"facilities":"P,S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)"]},{"id":21,"name":"Pethidine","formulations":["Injection: 50mg/ml"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)"]},{"id":22,"name":"Fentanyl","formulations":["Injection: 50 microgm/ml"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.2 Opioid analgesics"]},{"id":23,"name":"Morphine","formulations":["Tablet: 10mg, 15 mg"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.2 Opioid analgesics"]},{"id":24,"name":"Tramadol","formulations":["Tablet: 50mg,100mg","Capsule: 50mg,100mg","Injection: 50mg/ml","Suppository: 100mg"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.2 Opioid analgesics"]},{"id":25,"name":"Amitriptyline","formulations":["Tablet: 10 mg; 25 mg"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.3 Medicines for other common symptoms in palliative care"]},{"id":26,"name":"Dexamethasone","formulations":["Injection: 4 mg/ml"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.3 Medicines for other common symptoms in palliative care"]},{"id":27,"name":"Diazepam","formulations":["Injection: 5 mg/ml.","Suppository: 10mg","Tablet: 5 mg; 10 mg."],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.3 Medicines for other common symptoms in palliative care"]},{"id":28,"name":"Fluoxetine","formulations":["Tablet: 10mg, 20 mg"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.3 Medicines for other common symptoms in palliative care"]},{"id":29,"name":"Hyoscine butylbromide","formulations":["Injection: 20 mg/ml.,","Tablet: 10mg, 20mg"],"facilities":"P,S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.3 Medicines for other common symptoms in palliative care"]},{"id":30,"name":"Lactulose","formulations":["Oral liquid: 3.5 g/5 ml"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.3 Medicines for other common symptoms in palliative care"]},{"id":31,"name":"Ondansetron","formulations":["Tablet: 4mg, 8mg","Injection: 8mg/4ml"],"facilities":"S,T","path":["2. MEDICINES FOR PAIN AND PALLIATIVE CARE","2.3 Medicines for other common symptoms in palliative care"]},{"id":32,"name":"Chlorpheniramine","formulations":["Syrup: 2 mg/5ml","Tablet: 4mg, 10mg"],"facilities":"P,S,T (but not in CC, FWC)","path":["3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS"]},{"id":33,"name":"Dexamethasone","formulations":["Injection: 4 mg/ml, 5mg/ml, 6mg/ml","Tablet: 0.5 mg; 0.75 mg; 1.5 mg; 2 mg; 4 mg , 6mg"],"facilities":"P,S,T (but not in CC, FWC)","path":["3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS"]},{"id":34,"name":"Epinephrine (adrenaline)","formulations":["Injection: 1 mg/ml"],"facilities":"P,S,T (but not in CC, FWC)","path":["3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS"]},{"id":35,"name":"Fexofenadine","formulations":["Suspension: 30 mg/5 ml","Tablet: 60 mg, 120mg, 180mg"],"facilities":"P,S,T","path":["3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS"]},{"id":36,"name":"Hydrocortisone","formulations":["Injection: 50 mg/ml","Tablet: 10mg, 20mg"],"facilities":"P,S,T (but not in CC, FWC)","path":["3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS"]},{"id":37,"name":"Methylprednisolone","formulations":["Tablet:2mg, 4mg, 8mg, 16mg"],"facilities":"S, T","path":["3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS"]},{"id":38,"name":"Prednisolone","formulations":["Tablet:2mg, 5mg,10mg , 20mg"],"facilities":"P,S,T (but not in CC, FWC)","path":["3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS"]},{"id":39,"name":"Atropine","formulations":["Injection: 1 mg / ml"],"facilities":"S,T","path":["4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS","4.1 Specific"]},{"id":40,"name":"Calcium Gluconate","formulations":["Injection: 100 mg/ml"],"facilities":"S,T","path":["4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS","4.1 Specific"]},{"id":41,"name":"Deferoxamine","formulations":["Injection: 500 mg/vial"],"facilities":"T","path":["4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS","4.1 Specific"]},{"id":42,"name":"Naloxone","formulations":["Injection: 400 micrograms / ml"],"facilities":"S , T","path":["4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS","4.1 Specific"]},{"id":43,"name":"Pralidoxime","formulations":["Injection: 500mg/ml, 1000mg/ml"],"facilities":"S,T","path":["4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS","4.1 Specific"]},{"id":44,"name":"Carbamazepine","formulations":["Oral liquid: 100 mg/5 ml.","Tablet (chewable): 100 mg; 200 mg.","Tablet (scored): 100 mg; 200 mg; 400 mg."],"facilities":"S,T","path":["5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","5.1 Antiseizure medicines"]},{"id":45,"name":"Diazepam","formulations":["Injection: 5 mg/ml.","Oral liquid: 2 mg/5 ml.","Tablet (scored): 5 mg; 10 mg."],"facilities":"S,T","path":["5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","5.1 Antiseizure medicines"]},{"id":46,"name":"Magnesium Sulphate","formulations":["Injection 500 mg/ml","*For use in eclampsia and severe pre-eclampsia and not for other convulsant disorders."],"facilities":"S,T","path":["5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","5.1 Antiseizure medicines"]},{"id":47,"name":"Phenobarbital","formulations":["Injection: 200 mg/ml (sodium).","Oral liquid: 15 mg/5 ml.","Tablet: 15 mg to 100 mg."],"facilities":"S,T","path":["5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","5.1 Antiseizure medicines"]},{"id":48,"name":"Phenytoin","formulations":["Injection: 50 mg/ml","Oral liquid: 30 mg/5 ml","Tablet: 25 mg; 50 mg; 100 mg","Tablet (chewable): 50 mg"],"facilities":"S,T","path":["5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","5.1 Antiseizure medicines"]},{"id":49,"name":"Levodopa + carbidopa","formulations":["Tablet: 100 mg + 10 mg; 100 mg + 25 mg; 250 mg + 25 mg."],"facilities":"S,T","path":["5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","5.2 Medicines for parkinsonism"]},{"id":50,"name":"Procyclidine","formulations":["Injection: 10 mg/2ml","Tablet: 5 mg."],"facilities":"S,T","path":["5. MEDICINES FOR DISEASES OF THE NERVOUS SYSTEM","5.2 Medicines for parkinsonism"]},{"id":51,"name":"Albendazole","formulations":["Tablet (chewable, scored): 400 mg."],"facilities":"P,S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.1 Anthelminthics","6.1.1 Intestinal anthelminthics"]},{"id":52,"name":"Ivermectin","formulations":["Tablet: 3mg, 6 mg, 12 mg"],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.1 Anthelminthics","6.1.1 Intestinal anthelminthics"]},{"id":53,"name":"Mebendazole","formulations":["Tablet (chewable, scored): 100 mg.","Suspension: 100mg/5ml"],"facilities":"P,S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.1 Anthelminthics","6.1.1 Intestinal anthelminthics"]},{"id":54,"name":"Amikacin","formulations":["Injection: 250 mg/ml (as sulfate) in 2 ml vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":55,"name":"Amoxicillin","formulations":["Powder for injection: 250 mg; 500 mg; 1 g (as sodium) in vial.","Powder for oral liquid: 125 mg/5 ml","Tablet: 250 mg; 500 mg; 1g (as trihydrate).","Tablet (dispersible, scored): 250 mg"],"facilities":"P (Except CC), S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":56,"name":"Amoxicillin + clavulanic acid","formulations":["Powder for injection: 500 mg (as sodium) + 100 mg (as potassium salt); 1000 mg (as sodium) + 200 mg (as potassium salt) in vial.","Powder for oral liquid: 125 mg (as trihydrate)+ 31.25 mg (as potassium salt)/5 ml;","Tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":57,"name":"Benzathine benzylpenicillin","formulations":["Powder for injection: 1.2 million IU (≈ 900 mg) in vial [c]; 2.4 million IU (≈ 1.8 g) in vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":58,"name":"Cefalexin","formulations":["Powder for oral liquid: 125 mg/5 ml; 250 mg/5 ml (anhydrous).","Capsule: 250 mg; 500 mg"],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":59,"name":"Cefradine","formulations":["Powder for oral liquid: 125 mg/5 ml; 250 mg/5 ml (anhydrous).","Tablet: 250 mg; 500 mg (as monohydrate).","Injection: 500mg, 1g"],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":60,"name":"Clindamycin","formulations":["Capsule: 150 mg (as hydrochloride).","Injection: 150 mg/ml (as phosphate); 600 mg/4 ml (as phosphate); 900 mg/6 ml (as phosphate)."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":61,"name":"Cloxacillin","formulations":["Capsule: 500 mg; 1 g (as sodium).","Powder for injection: 500 mg (as sodium) in vial."],"facilities":"P (Except CC), S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":62,"name":"Doxycycline","formulations":["Powder for injection: 100 mg in vial.","Tablet: 100 mg (as hyclate).","Tablet (dispersible): 100 mg (as monohydrate)","Capsule:"],"facilities":"P (Except CC), S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":63,"name":"Flucloxacillin","formulations":["Capsule: 250mg, 500 mg","Injection: 250mg, 500 mg in vial."],"facilities":"P (Except CC), S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":64,"name":"Gentamicin","formulations":["Injection: 10 mg/ml (as sulfate); 40 mg/ml (as sulfate) in 2 ml vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":65,"name":"Metronidazole","formulations":["Injection: 500 mg in 100 ml vial.","Oral liquid: 200 mg/5 ml (as benzoate).","Suppository: 500 mg; 1 g.","Tablet: 200 mg; 250 mg; 400 mg; 500 mg."],"facilities":"P (Except CC), S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":66,"name":"Nitrofurantoin","formulations":["Tablet: 100 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":67,"name":"Phenoxymethylpenicillin","formulations":["Powder for oral liquid: 250 mg/5 ml (as potassium).","Tablet: 250 mg; 500 mg (as potassium)."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":68,"name":"Sulfamethoxazole + Trimethoprim","formulations":["Injection: 80 mg + 16 mg/ml in 5 ml ampoule; 80 mg + 16 mg/ml in 10 ml ampoule.","Oral liquid: 200 mg + 40 mg/5 ml.","Tablet: 100 mg + 20 mg; 400 mg + 80 mg; 800 mg + 160 mg."],"facilities":"P (Except CC), S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.1 Access group of antibiotics"]},{"id":69,"name":"Azithromycin","formulations":["Tablet: 250 mg; 500 mg (anhydrous)."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":70,"name":"Cefixime","formulations":["Tablet: 200 mg; 400 mg (as trihydrate)."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":71,"name":"Ceftazidime","formulations":["Powder for injection: 250 mg; 1 g (as sodium) in vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":72,"name":"Ceftriaxone","formulations":["Powder for injection: 250 mg; 500 mg; 1 g; 2 g (as sodium) in vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":73,"name":"Cefuroxime","formulations":["Powder for injection: 250 mg; 750 mg; 1.5 g (as sodium) in vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":74,"name":"Ciprofloxacin","formulations":["Tablet: 250 mg; 500 mg (as hydrochloride)."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":75,"name":"Clarithromycin","formulations":["Powder for oral liquid: 125 mg/5 ml; 250 mg/5 ml.","Powder for injection: 500 mg in vial.","Tablet: 500 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":76,"name":"Meropenem","formulations":["Powder for injection: 500 mg (as trihydrate); 1 g (as trihydrate) in vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":77,"name":"Piperacillin + Tazobactam","formulations":["Powder for injection: 2 g (as sodium) + 250 mg (as sodium); 4 g (as sodium) + 500 mg (as sodium) in vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":78,"name":"Vancomycin","formulations":["Capsule: 125 mg; 250 mg (as hydrochloride) in vial.","*vancomycin powder for injection may also be used for oral administration"],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.2 Watch group antibiotics"]},{"id":79,"name":"Clofazimine","formulations":["Tablet: 50 mg; 100 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.3 Antileprosy medicines"]},{"id":80,"name":"Dapsone","formulations":["Tablet: 25 mg; 50 mg; 100 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.3 Antileprosy medicines"]},{"id":81,"name":"Rifampicin","formulations":["Tablet: 150 mg; 300 mg"],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.3 Antileprosy medicines"]},{"id":82,"name":"Bedaquiline","formulations":["Tablet: 100 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":83,"name":"Clofazimine","formulations":["Tablet: 50 mg; 100 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":84,"name":"Cycloserine","formulations":["Tablet: 250 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":85,"name":"Delamanid","formulations":["Tablet: 50 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":86,"name":"Ethambutol + Isoniazid + Pyrazinamide + Rifampicin (4FDC)","formulations":["Tablet: 275 mg + 75 mg + 400 mg + 150 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":87,"name":"Ethionamide","formulations":["Tablet: 250 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":88,"name":"Isoniazid","formulations":["Tablet: 100 mg; 300 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":89,"name":"Isoniazid + Rifampicin (2FDC)","formulations":["Tablet: 75 mg + 150 mg; 150 mg + 300 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":90,"name":"Isoniazid + Rifapentine (3HP)","formulations":["Tablet (scored): 300 mg + 300 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":91,"name":"Levofloxacin","formulations":["Tablet: 250mg; 500 mg; 750 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":92,"name":"Linezolid","formulations":["Tablet: 600 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":93,"name":"Prothionamide","formulations":["Tab. 250 mg"],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":94,"name":"Pretomanid","formulations":["Tablet: 200 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":95,"name":"Rifapentine","formulations":["Tablet: 150 mg; 300 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.2 Antibacterial","6.2.4 Antituberculosis medicines"]},{"id":96,"name":"Clotrimazole","formulations":["Vaginal cream: 1%; 10%.","Vaginal tablet: 100 mg; 500 mg."],"facilities":"P,S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.3 Antifungal medicines"]},{"id":97,"name":"Fluconazole","formulations":["Capsule: 50 mg.","Injection: 2 mg/ml in vial.","Oral liquid: 50 mg/5 ml."],"facilities":"P,S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.3 Antifungal medicines"]},{"id":98,"name":"Itraconazole","formulations":["Capsule: 100 mg.","Oral liquid: 10 mg/ml."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.3 Antifungal medicines"]},{"id":99,"name":"Nystatin","formulations":["Pessary: 100 000 IU.","Tablet: 500 000 IU.","Oral Suspension: 500,000unit, 100000 unit / ml"],"facilities":"P,S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.3 Antifungal medicines"]},{"id":100,"name":"Acyclovir","formulations":["Powder for injection: 250 mg (as sodium salt) in vial.","Tablet: 200 mg"],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.1 Antiherpes medicines"]},{"id":101,"name":"Abacavir (ABC)","formulations":["Tablet: 300 mg (as sulfate)."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors"]},{"id":102,"name":"Lamivudine (3TC)","formulations":["Tablet: 150 mg."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors"]},{"id":103,"name":"Tenofovir disoproxil fumarate (TDF)","formulations":["Tablet: 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil)."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors"]},{"id":104,"name":"Zidovudine (ZDV or AZT)","formulations":["Capsule: 250 mg.","Oral liquid: 50 mg/5 ml.","Solution for IV infusion: 10 mg/ml in 20 ml vial.","Tablet: 300 mg."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors"]},{"id":105,"name":"Lopinavir + ritonavir","formulations":["Tablet (heat stable): 100 mg + 25 mg; 200 mg + 50 mg."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.2 Protease inhibitors"]},{"id":106,"name":"Dolutegravir","formulations":["Tablet: 10mg, 50mg"],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.3 Integrase inhibitors"]},{"id":107,"name":"Abacavir + Dolutegravir + Lamivudine","formulations":["Tablet (dispersible): 60 mg (as sulfate) + 5 mg + 30 mg."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.4 Fixed-dose combinations of antiretroviral medicines"]},{"id":108,"name":"Abacavir + lamivudine","formulations":["Tablet (dispersible, scored): 120 mg (as sulfate) + 60 mg."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.4 Fixed-dose combinations of antiretroviral medicines"]},{"id":109,"name":"Dolutegravir + lamivudine + tenofovir","formulations":["Tablet: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil)"],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.4 Fixed-dose combinations of antiretroviral medicines"]},{"id":110,"name":"Efavirenz + lamivudine + tenofovir","formulations":["Tablet: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil)"],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.2 Antiretrovirals","6.4.2.4 Fixed-dose combinations of antiretroviral medicines"]},{"id":111,"name":"Tenofovir disoproxil fumarate (TDF)","formulations":["Tablet: 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil)."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.3 Antihepatitis medicines","6.4.3.1 Medicines for hepatitis B","6.4.3.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors"]},{"id":112,"name":"Sofosbuvir + velpatasvir","formulations":["Tablet:; 400 mg + 100 mg."],"facilities":"T","path":["6. ANTI-INFECTIVE MEDICINES","6.4 Antiviral medicines","6.4.3 Antihepatitis medicines","6.4.3.2 Medicines for hepatitis C","6.4.3.2.1 Pangenotypic direct-acting antiviral combinations"]},{"id":113,"name":"Metronidazole","formulations":["Injection: 500 mg in 100 ml vial.","Oral liquid: 200 mg/5 ml (as benzoate).","Tablet: 200 mg; 250 mg; 400 mg; 500 mg."],"facilities":"P (except CC),S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.5 Antiprotozoal medicines","6.5.1 Antiamoebic and antigiardiasis medicines"]},{"id":114,"name":"Amphotericin B","formulations":["Powder for injection: 50 mg (liposomal complex) in vial."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.5 Antiprotozoal medicines","6.5.2 Antileishmaniasis medicines"]},{"id":115,"name":"Artemether + Lumefantrine","formulations":["Tablet: 20 mg + 120 mg."],"facilities":"P (except CC),S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.5 Antiprotozoal medicines","6.5.3 Antimalarial medicines","6.5.3.1 For curative treatment"]},{"id":116,"name":"Artesunate","formulations":["Powder for injection: 30 mg; 60 mg; 120 mg in vial."],"facilities":"P (except CC),S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.5 Antiprotozoal medicines","6.5.3 Antimalarial medicines","6.5.3.1 For curative treatment"]},{"id":117,"name":"Primaquine","formulations":["Tablet: 7.5 mg; 15 mg (as diphosphate)."],"facilities":"P (except CC),S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.5 Antiprotozoal medicines","6.5.3 Antimalarial medicines","6.5.3.1 For curative treatment"]},{"id":118,"name":"Sulfamethoxazole + Trimethoprim","formulations":["Injection: 80 mg + 16 mg/ml in 5 ml ampoule; 80 mg + 16 mg/ml in 10 ml ampoule.","Tablet: ; 800 mg + 160 mg."],"facilities":"S,T","path":["6. ANTI-INFECTIVE MEDICINES","6.5 Antiprotozoal medicines","6.5.4 Antipneumocystosis and antitoxoplasmosis medicines"]},{"id":119,"name":"Acetylsalicylic acid (Aspirin)","formulations":["Tablet: 300 mg , 500 mg."],"facilities":"P,S,T","path":["7. ANTIMIGRAINE MEDICINES","7.1 For treatment of acute attack"]},{"id":120,"name":"Ibuprofen","formulations":["Tablet: 200 mg; 400 mg."],"facilities":"P,S,T","path":["7. ANTIMIGRAINE MEDICINES","7.1 For treatment of acute attack"]},{"id":121,"name":"Paracetamol (acetaminophen)","formulations":["Oral liquid: 120 mg/5 ml or 125 mg/5 ml*;","*The presence of both 120 mg/5 ml and 125 mg/5ml strengths on the same market would cause confusion in prescribing and dispensing and should be avoided.","Tablet: 250 mg; 325 mg; 500 mg.","Tablet (dispersible): 100 mg"],"facilities":"P,S,T","path":["7. ANTIMIGRAINE MEDICINES","7.1 For treatment of acute attack"]},{"id":122,"name":"Propranolol","formulations":["Tablet: 20 mg; 40 mg (hydrochloride)."],"facilities":"S,T","path":["7. ANTIMIGRAINE MEDICINES","7.2 For prophylaxis"]},{"id":123,"name":"Azathioprine","formulations":["Powder for injection:100 mg (as sodium salt) in vial.","Tablet (scored): 50 mg."],"facilities":"S,T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.1 Immunomodulators for non-malignant disease"]},{"id":124,"name":"Asparaginase / Crisantaspase/ L-asparaginase","formulations":["Powder for injection: 10 000 IU in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":125,"name":"Bleomycin","formulations":["Powder for injection|: 15000 IU (as sulfate) in vial"],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":126,"name":"Calcium folinate (leucovorin calcium)","formulations":["Injection: 3 mg/ml in 10 ml ampoule; 7.5 mg/ml in 2 ml ampoule; 10 mg/ml in 5 ml ampoule.","Tablet: 5 mg; 15 mg; 25 mg."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":127,"name":"Capecitabine","formulations":["Tablet: 150 mg; 500 mg."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":128,"name":"Carboplatin","formulations":["Injection: 50 mg/5 ml; 150 mg/15 ml; 450 mg/45 ml; 600 mg/60 ml."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":129,"name":"Cisplatin","formulations":["Injection: 10 mg/10 ml; 20 mg/20 ml; 50 mg/50 ml; 100 mg/100 ml."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":130,"name":"Cyclophosphamide","formulations":["Powder for injection: 500 mg; 1 g; 2 g in vial.","Tablet: 25 mg; 50 mg."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":131,"name":"Dactinomycin / Actinomycin D","formulations":["Powder for injection: 500 micrograms in vial"],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":132,"name":"Docetaxel","formulations":["Injection: 20 mg/ml; 40 mg/ml."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":133,"name":"Doxorubicin","formulations":["Injection: 2 mg/ml (hydrochloride) in vial.","Powder for injection: 10 mg; 50 mg (hydrochloride) in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":134,"name":"Etoposide","formulations":["Capsule: 50 mg, 100 mg.","Injection: 20 mg/ml in 5 ml ampoule.","Powder for injection: 100 mg (as phosphate) in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":135,"name":"Fluorouracil","formulations":["Injection: 50 mg/ml in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":136,"name":"Gemcitabine","formulations":["Powder for injection: 200 mg; 1 g in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":137,"name":"Ifosfamide","formulations":["Powder for injection: 200 mg; 1 g in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":138,"name":"Melphalan","formulations":["Tablet: 2 mg","Powder for injection: 50 mg in vial"],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":139,"name":"Mercaptopurine","formulations":["Tablet: 50 mg."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":140,"name":"Methotrexate","formulations":["Tablet: 2.5mg, 10 mg , 15 mg","Injection: 25mg/ml"],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":141,"name":"Oxaliplatin","formulations":["Injection: 50 mg/10 ml in 10 ml vial; 100 mg/20 ml in 20 ml vial; 200 mg/40 ml in 40 ml vial.","Powder for injection: 50 mg; 100 mg in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":142,"name":"Paclitaxel","formulations":["Injection: 6 mg/ml in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":143,"name":"Vinblastine","formulations":["Injection: 10 mg/10 ml (sulfate) in vial.","Powder for injection: 10 mg (sulfate) in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":144,"name":"Vincristine","formulations":["Injection: 1 mg/ml (sulfate); 2 mg/2 ml (sulfate) in vial.","Powder for injection: 1 mg; 5 mg (sulfate) in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.1 Cytotoxic Medicines"]},{"id":145,"name":"Erlotinib","formulations":["Capsule: 50 mg, 100 mg.","Injection: 20 mg/ml in 5 ml ampoule.","Powder for injection: 100 mg (as phosphate) in vial."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.2 Targeted therapies"]},{"id":146,"name":"Gefitinib","formulations":["Tablet: 100 mg, 150 mg."],"facilities":"S (Except UHC), T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.2 Targeted therapies"]},{"id":147,"name":"Imatinib","formulations":["Tablet: 100 mg; 400 mg."],"facilities":"T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.2 Targeted therapies"]},{"id":148,"name":"Rituximab -including quality-assured biosimilars","formulations":["Injection (intravenous): 100 mg/10 ml in 10 ml vial; 500 mg/50 ml in 50 ml vial."],"facilities":"T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.2 Targeted therapies"]},{"id":149,"name":"Trastuzumab -including quality-assured biosimilars","formulations":["Powder for injection: 60 mg; 150 mg; 440 mg in vial."],"facilities":"T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.2 Targeted therapies"]},{"id":150,"name":"Filgrastim","formulations":["Injection: 120 micrograms/0.2 ml; 300 micrograms/0.5 ml; in pre-filled syringe.","Injection: 300 micrograms/ml in 1 ml vial;"],"facilities":"T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.3 Immunomodulators"]},{"id":151,"name":"Anastrozole","formulations":["Tablet: 1 mg."],"facilities":"T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.4 Hormones and antihormones"]},{"id":152,"name":"Bicalutamide","formulations":["Tablet: 50 mg."],"facilities":"T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.4 Hormones and antihormones"]},{"id":153,"name":"Tamoxifen","formulations":["Tablet: 10 mg; 20 mg (as citrate)."],"facilities":"T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.4 Hormones and antihormones"]},{"id":154,"name":"Allopurinol","formulations":["Tablet: 100 mg; 300 mg."],"facilities":"S,T","path":["8. IMMUNOMODULATORS AND ANTINEOPLASTICS","8.2 Antineoplastics and supportive medicines","8.2.5 Supportive medicines"]},{"id":155,"name":"Ferrous salt","formulations":["Tablet: equivalent to 60 mg iron."],"facilities":"P,S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.1 Antianaemia medicines"]},{"id":156,"name":"Ferrous salt + Folic Acid","formulations":["Tablet: equivalent to 60 mg elemental iron + 400 micrograms folic acid.*","*nutritional supplement for use during pregnancy","Tablet: equivalent to 60 mg elemental iron + 2.8 mg folic acid."],"facilities":"P,S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.1 Antianaemia medicines"]},{"id":157,"name":"Folic Acid (Vitamin B9)","formulations":["Tablet: 400 micrograms*; 1 mg; 5 mg."],"facilities":"P,S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.1 Antianaemia medicines"]},{"id":158,"name":"Hydroxocobalamin","formulations":["Injection: 1 mg/ml (as acetate, as hydrochloride or as sulfate) in 1 ml ampoule."],"facilities":"S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.1 Antianaemia medicines"]},{"id":159,"name":"Enoxaparin","formulations":["Injection: ampoule or pre-filled syringe 20 mg/0.2 ml; 40 mg/0.4 ml; 60 mg/0.6 ml; 80 mg/0.8 ml; 100 mg/1 ml; 120 mg/0.8 ml; 150 mg/1 ml."],"facilities":"S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.2 Medicines affecting coagulation"]},{"id":160,"name":"Heparin sodium","formulations":["Injection: 1000 IU/ml; 5000 IU/ml; 20 000 IU/ml in 1 ml ampoule."],"facilities":"S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.2 Medicines affecting coagulation"]},{"id":161,"name":"Phytomenadione (Vitamin K)","formulations":["Injection: 10 mg/ml in ampoule.","Injection (mixed micelle solution): 2 mg/0.2 ml; 10 mg/ml in ampoule.","Tablet: 5 mg."],"facilities":"S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.2 Medicines affecting coagulation"]},{"id":162,"name":"Rivaroxaban","formulations":["Tablet: 2.5 mg, 10 mg, 15 mg, 20 mg"],"facilities":"S,T","path":["9. MEDICINES AFFECTING THE BLOOD","9.2 Medicines affecting coagulation"]},{"id":163,"name":"ACD Blood Pack/Double Bag/Triple Bag","formulations":[],"facilities":"S,T","path":["10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","10.1 Blood and blood components"]},{"id":164,"name":"Anti-D immunoglobulin","formulations":["Injection: 250 micrograms in single-dose vial."],"facilities":"S,T","path":["10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","10.2 Plasma-derived medicines","10.2.1 Human immunoglobulins"]},{"id":165,"name":"Anti-rabies immunoglobulin","formulations":["Injection: 150 IU/ml in vial."],"facilities":"S,T","path":["10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","10.2 Plasma-derived medicines","10.2.1 Human immunoglobulins"]},{"id":166,"name":"Anti-tetanus immunoglobulin","formulations":["Injection: 500 IU in vial."],"facilities":"S,T","path":["10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","10.2 Plasma-derived medicines","10.2.1 Human immunoglobulins"]},{"id":167,"name":"Coagulation Factor VIII","formulations":["Powder for injection: 250 IU; 500 IU; 1000 IU in vial."],"facilities":"S,T","path":["10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","10.2 Plasma-derived medicines","10.2.2 Blood Coagulation factors"]},{"id":168,"name":"Coagulation Factor IX","formulations":["Powder for injection: 500 IU; 1000 IU in vial."],"facilities":"T","path":["10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","10.2 Plasma-derived medicines","10.2.2 Blood Coagulation factors"]},{"id":169,"name":"Albumin","formulations":["Injectable solution: 5%, 20%, 25%"],"facilities":"S,T","path":["10. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES","10.3 Plasma Substitutes"]},{"id":170,"name":"Bisoprolol","formulations":["Tablet: 1.25 mg; 2.5 mg, 5 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.1 Antianginal medicines"]},{"id":171,"name":"Glyceryl Trinitrate (Nitroglycerin)","formulations":["Tablet:sublingual 500 micrograms.; Oral: 2.6 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.1 Antianginal medicines"]},{"id":172,"name":"Metoprolol","formulations":["Tablet: 1.25 mg; 2.5 mg, 5 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.1 Antianginal medicines"]},{"id":173,"name":"Amiodarone","formulations":["Injection: 50 mg/ml (hydrochloride) in 3 ml ampoule.","Tablet: 100 mg; 200 mg; 400 mg (hydrochloride)."],"facilities":"T","path":["11. CARDIOVASCULAR MEDICINES","11.2 Antiarrhythmic medicines"]},{"id":174,"name":"Bisoprolol","formulations":["Tablet: 1.25 mg; 2.5 mg, 5mg."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.2 Antiarrhythmic medicines"]},{"id":175,"name":"Digoxin","formulations":["Injection: 250 micrograms/ml in 2 ml ampoule.","Oral liquid: 25 microgram/5ml","Tablet: 250 micrograms."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.2 Antiarrhythmic medicines"]},{"id":176,"name":"Epinephrine (Adrenaline)","formulations":["Injection: 100 micrograms/ml (as acid tartrate or hydrochloride) in 10 ml ampoule."],"facilities":"S, T","path":["11. CARDIOVASCULAR MEDICINES","11.2 Antiarrhythmic medicines"]},{"id":177,"name":"Lidocaine","formulations":["Injection, 20 mg/ml (5 ml ampoule)"],"facilities":"S, T","path":["11. CARDIOVASCULAR MEDICINES","11.2 Antiarrhythmic medicines"]},{"id":178,"name":"Metoprolol","formulations":["Tablet: 1.25 mg; 2.5 mg, 5mg."],"facilities":"S, T","path":["11. CARDIOVASCULAR MEDICINES","11.2 Antiarrhythmic medicines"]},{"id":179,"name":"Verapamil","formulations":["Injection: 2.5 mg/ml (hydrochloride) in 2 ml ampoule.","Tablet: 40 mg; 80 mg (hydrochloride)."],"facilities":"S, T","path":["11. CARDIOVASCULAR MEDICINES","11.2 Antiarrhythmic medicines"]},{"id":180,"name":"Amlodipine","formulations":["Tablet: 5 mg, 10 mg (as maleate, mesylate or besylate)."],"facilities":"P, S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":181,"name":"Atenolol","formulations":["Tablet: 25mg, 50mg, 100mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":182,"name":"Bisoprolol","formulations":["Tablet: 1.25mg, 2.5mg, 5mg, 7.5mg, 10mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":183,"name":"Enalapril","formulations":["Tablet: 2.5 mg; 5 mg; 10 mg (as hydrogen maleate)."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":184,"name":"Hydrochlorothiazide","formulations":["Tablet: 12.5 mg; 25 mg."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":185,"name":"Labetalol","formulations":["Tablet: 100mg, 200mg","Injection: 50 mg/10 ml"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":186,"name":"Losartan","formulations":["Tablet: 25 mg; 50 mg; 100 mg."],"facilities":"P,S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":187,"name":"Methyldopa","formulations":["Tablet: 250 mg."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":188,"name":"Nifedipine","formulations":["Capsule: 10 mg.","Tablet: 20mg, 30mg, 60mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":189,"name":"Telmisartan + Amlodipine","formulations":["Tablet 40 mg + 5 mg, 80 mg + 5 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":190,"name":"Telmisartan + Hydrochlorothiazide","formulations":["Tablet 40 mg + 12.5 mg, 80 mg + 12.5 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.3 Antihypertensive medicines"]},{"id":191,"name":"Bisoprolol","formulations":["Tablet: 1.25 mg, 2.5mg, 5 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":192,"name":"Digoxin","formulations":["Injection: 250 micrograms/ml in 2 ml ampoule.","Oral liquid: 50 micrograms/ml.","Tablet: 62.5 micrograms; 250 micrograms."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":193,"name":"Empagliflozin","formulations":["Tablet:10 mg, 25mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":194,"name":"Furosemide","formulations":["Injection: 10 mg/ml in 2 ml, 5 ml ampoule.","Tablet: 20 mg; 40 mg."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":195,"name":"Hydrochlorothiazide","formulations":["Tablet: 25 mg."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":196,"name":"Losartan","formulations":["Tablet: 25 mg; 50 mg; 100 mg."],"facilities":"P, S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":197,"name":"Spironolactone","formulations":["Tablet: 25 mg, 50 mg, 100 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":198,"name":"Nor-adrenaline (Norepinephrine)","formulations":["Injection: 1 mg/ml (base equivalent) , 4 mg/250 ml, 8 mg/250 ml)."],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.4 Medicines used in heart failure"]},{"id":199,"name":"Acetylsalicylic Acid (Aspirin)","formulations":["Tablet: 75mg"],"facilities":"P, S,T","path":["11. CARDIOVASCULAR MEDICINES","11.5 Antithrombotic medicines","11.5.1 Anti-platelet medicines"]},{"id":200,"name":"Clopidogrel","formulations":["Tablet: 75 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.5 Antithrombotic medicines","11.5.1 Anti-platelet medicines"]},{"id":201,"name":"Streptokinase","formulations":["Powder for injection: 1.5 million IU in vial."],"facilities":"S (Except UHC), T","path":["11. CARDIOVASCULAR MEDICINES","11.5 Antithrombotic medicines","11.5.2 Thrombolytic medicines"]},{"id":202,"name":"Atorvastatin","formulations":["Tablet: 10 mg; 20 mg"],"facilities":"S,T","path":["11. CARDIOVASCULAR MEDICINES","11.6 Lipid-lowering agents"]},{"id":203,"name":"Clotrimazole","formulations":["Cream: 1%, 2%","Vaginal Pessary: 100mg, 500mg"],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.1 Antifungal medicines"]},{"id":204,"name":"Miconazole","formulations":["Cream or ointment: 2% (nitrate)."],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.1 Antifungal medicines"]},{"id":205,"name":"Potassium Permanganate","formulations":["Aqueous solution: 1:10 000"],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.2 Anti-infective medicines"]},{"id":206,"name":"Silver sulfadiazine","formulations":["Cream: 1%"],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.2 Anti-infective medicines"]},{"id":207,"name":"Betamethasone","formulations":["Cream or ointment: 0.1% (as valerate)."],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.3 Anti-inflammatory and antipruritic medicines"]},{"id":208,"name":"Calamine","formulations":["Lotion"],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.3 Anti-inflammatory and antipruritic medicines"]},{"id":209,"name":"Salicylic acid","formulations":["Solution: 5%."],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.4 Medicines affecting skin differentiation and proliferation"]},{"id":210,"name":"Benzyl Benzoate","formulations":["Lotion: 25%."],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.5 Scabicides and pediculicides"]},{"id":211,"name":"Permethrin","formulations":["Cream: 5%. Lotion: 1%."],"facilities":"P,S,T","path":["12. DERMATOLOGICAL MEDICINES","12.5 Scabicides and pediculicides"]},{"id":212,"name":"Fluorescein","formulations":["Eye drops: 1% (sodium salt)."],"facilities":"S,T","path":["13. DIAGNOSTIC AGENTS","13.1 Ophthalmic medicines"]},{"id":213,"name":"Tropicamide","formulations":["Eye drops: 0.5%."],"facilities":"S,T","path":["13. DIAGNOSTIC AGENTS","13.1 Ophthalmic medicines"]},{"id":214,"name":"Barium Sulphate (X-Ray Grade)","formulations":["Aqueous Suspension, Powder (addition)"],"facilities":"S,T","path":["13. DIAGNOSTIC AGENTS","13.2 Radiocontrast media"]},{"id":215,"name":"Gadoterate meglumine","formulations":["Injection, 10 ml"],"facilities":"T","path":["13. DIAGNOSTIC AGENTS","13.2 Radiocontrast media"]},{"id":216,"name":"Iohexol","formulations":["Injection: 140 mg to 350 mg iodine/ml in 5 ml, 10 ml, 20 ml ampoule."],"facilities":"S,T","path":["13. DIAGNOSTIC AGENTS","13.2 Radiocontrast media"]},{"id":217,"name":"Chlorhexidine","formulations":["Solution: 5% (digluconate)."],"facilities":"P,S,T","path":["14. ANTISEPTICS AND DISINFECTANTS","14.1 Antiseptics"]},{"id":218,"name":"Povidone Iodine","formulations":["Solution: 10% (equivalent to 1% available iodine)."],"facilities":"P,S,T","path":["14. ANTISEPTICS AND DISINFECTANTS","14.1 Antiseptics"]},{"id":219,"name":"Alcohol based hand rub","formulations":["Solution: containing ethanol 80% volume/volume.","Solution: containing isopropyl alcohol 75% volume/volume."],"facilities":"P,S,T","path":["14. ANTISEPTICS AND DISINFECTANTS","14.2 Disinfectants"]},{"id":220,"name":"Chloroxylenol","formulations":["Solution: 4.8%."],"facilities":"P,S,T","path":["14. ANTISEPTICS AND DISINFECTANTS","14.2 Disinfectants"]},{"id":221,"name":"Furosemide","formulations":["Injection: 10 mg/ml in 2 ml, 5 ml ampoule.","Oral liquid: 20 mg/5 ml","Tablet: 20 mg; 40 mg."],"facilities":"S,T","path":["15. DIURETICS"]},{"id":222,"name":"Hydrochlorothiazide","formulations":["Tablet: 25 mg."],"facilities":"S,T","path":["15. DIURETICS"]},{"id":223,"name":"Spironolactone","formulations":["Tablet: 25 mg."],"facilities":"S,T","path":["15. DIURETICS"]},{"id":224,"name":"Aluminium Hydroxide + Magnesium Hydroxide","formulations":["Tablet: 250 mg + 400 mg","Oral liquid: (175mg+225mg)/5ml, (200mg+125mg)/5ml, (200mg+400mg)/5ml,"],"facilities":"P,S,T","path":["16. GASTROINTESTINAL MEDICINES","16.1 Antiulcer medicines"]},{"id":225,"name":"Famotidine","formulations":["Injection: 25 mg/ml (as hydrochloride) in 2 ml ampoule.","Oral liquid: 75 mg/5 ml (as hydrochloride).","Tablet: 150 mg (as hydrochloride)."],"facilities":"P,S,T","path":["16. GASTROINTESTINAL MEDICINES","16.1 Antiulcer medicines"]},{"id":226,"name":"Omeprazole","formulations":["Powder for injection: 40 mg in vial","Powder for oral liquid: 20 mg; 40 mg sachets.","Tablet: 10 mg; 20 mg; 40 mg."],"facilities":"P,S,T","path":["16. GASTROINTESTINAL MEDICINES","16.1 Antiulcer medicines"]},{"id":227,"name":"Domperidone","formulations":["Tablet:10mg","Suspension:5mg/5ml Drop:5mg/1ml"],"facilities":"P,S,T","path":["16. GASTROINTESTINAL MEDICINES","16.2 Antiemetic medicines"]},{"id":228,"name":"Ondansetron","formulations":["Injection: 2 mg base/ml in 2 ml ampoule (as hydrochloride).","Oral liquid: 4 mg base/5 ml.","Tablet: Eq 4 mg base; Eq 8 mg base; Eq 24 mg base."],"facilities":"S,T","path":["16. GASTROINTESTINAL MEDICINES","16.2 Antiemetic medicines"]},{"id":229,"name":"Hydrocortisone","formulations":["Tablet 5 mg, 10 mg , 20 mg","Powder for Injection 100 mg"],"facilities":"S,T","path":["16. GASTROINTESTINAL MEDICINES","16.3 Anti-inflammatory medicines"]},{"id":230,"name":"Methotrexate","formulations":["Tablet: 2.5mg, 10 mg , 15 mg","Injection: 25mg/ml"],"facilities":"S,T","path":["16. GASTROINTESTINAL MEDICINES","16.3 Anti-inflammatory medicines"]},{"id":231,"name":"Prednisolone","formulations":["Tablet: 5 mg, 10 mg, 20 mg"],"facilities":"S,T","path":["16. GASTROINTESTINAL MEDICINES","16.3 Anti-inflammatory medicines"]},{"id":232,"name":"Sulfasalazine","formulations":["Tablet: 500 mg."],"facilities":"S,T","path":["16. GASTROINTESTINAL MEDICINES","16.3 Anti-inflammatory medicines"]},{"id":233,"name":"Bisacodyl","formulations":["Tablet- 5 mg, 10mg"],"facilities":"S,T","path":["16. GASTROINTESTINAL MEDICINES","16.4 Laxatives"]},{"id":234,"name":"Glycerin/Glycerol","formulations":["Suppository: 1gm, 2gm"],"facilities":"P,S,T","path":["16. GASTROINTESTINAL MEDICINES","16.4 Laxatives"]},{"id":235,"name":"Lactulose","formulations":["Syrup- 3.35 gm/5ml"],"facilities":"S,T","path":["16. GASTROINTESTINAL MEDICINES","16.4 Laxatives"]},{"id":236,"name":"Oral Rehydration Salts (ORS)","formulations":["Powder for dilution in 500 ml"],"facilities":"P, S,T","path":["16. GASTROINTESTINAL MEDICINES","16.5 Medicines used in diarrhoea","16.5.1 Oral rehydration"]},{"id":237,"name":"Zinc sulfate","formulations":["Tablet: 20 mg."],"facilities":"P, S,T","path":["16. GASTROINTESTINAL MEDICINES","16.5 Medicines used in diarrhoea","16.5.2 Medicines for diarrhoea"]},{"id":238,"name":"Hydrocortisone","formulations":["Tablet: 5 mg; 10 mg; 20 mg."],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.1 Adrenal hormones and synthetic substitutes"]},{"id":239,"name":"Prednisolone","formulations":["Tablet: 1 mg."],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.1 Adrenal hormones and synthetic substitutes"]},{"id":240,"name":"Medroxyprogesterone acetate","formulations":["Tablet: 5 mg."],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.2 Progestogens"]},{"id":241,"name":"Norethisterone acetate","formulations":["Tablet: 5 mg."],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.2 Progestogens"]},{"id":242,"name":"Insulin injection (soluble)","formulations":[],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.3 Medicines for diabetes","17.3.1 Insulins"]},{"id":243,"name":"Intermediate-acting insulin","formulations":[],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.3 Medicines for diabetes","17.3.1 Insulins"]},{"id":244,"name":"Premixed insulin (30/70)","formulations":[],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.3 Medicines for diabetes","17.3.1 Insulins"]},{"id":245,"name":"Empagliflozin","formulations":["Tablet: 10 mg; 25 mg."],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.3 Medicines for diabetes","17.3.2 Oral Hypoglycemic agents"]},{"id":246,"name":"Gliclazide","formulations":["Tablet: 30 mg, 60 mg, 80 mg"],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.3 Medicines for diabetes","17.3.2 Oral Hypoglycemic agents"]},{"id":247,"name":"Metformin","formulations":["Tablet: 500 mg, 850 mg, 1000 mg"],"facilities":"P,S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.3 Medicines for diabetes","17.3.2 Oral Hypoglycemic agents"]},{"id":248,"name":"Carbimazole","formulations":["Tablet: 5mg, 10 mg,"],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.4 Thyroid hormones and antithyroid medicines"]},{"id":249,"name":"Levothyroxine","formulations":["Tablet: 12.5mcg, 25mcg, 50mcg, 75mcg, 100mcg"],"facilities":"S,T","path":["17. MEDICINES FOR ENDOCRINE DISORDERS","17.4 Thyroid hormones and antithyroid medicines"]},{"id":250,"name":"Tuberculin, purified protein derivative (PPD)","formulations":["Injection"],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.1 Diagnostic agents"]},{"id":251,"name":"Antivenom immunoglobulin","formulations":["Injection"],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.2 Sera, immunoglobulins and monoclonal antibodies"]},{"id":252,"name":"Diphtheria antitoxin","formulations":["Injection: 10 000 IU; 20 000 IU in vial."],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.2 Sera, immunoglobulins and monoclonal antibodies"]},{"id":253,"name":"BCG Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":254,"name":"bOPV Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":255,"name":"Cholera Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":256,"name":"Hepatitis B Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":257,"name":"Human Papilloma Virus (HPV) Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":258,"name":"Influenza vaccine (seasonal)","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":259,"name":"MR Vaccine (Measles & Rubella)","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":260,"name":"Pentavalent vaccine (DPT, HepatitisB , Hib)","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":261,"name":"Pneumococcal Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":262,"name":"Poliomyelitis Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":263,"name":"Tetanus Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":264,"name":"TD Vaccine (Tetanus and Diphtheria)","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":265,"name":"Typhoid Conjugate Vaccine","formulations":[],"facilities":"S,T","path":["18. IMMUNOLOGICALS","18.3 Vaccines"]},{"id":266,"name":"Atracurium","formulations":["Injection: 10 mg/ml (besylate)."],"facilities":"S,T","path":["19. MUSCLE RELAXANTS (PERIPHERALLY- ACTING) AND CHOLINESTERASE INHIBITORS"]},{"id":267,"name":"Neostigmine","formulations":["Injection: 500 micrograms/ml (methylsulfate) in 1 ml ampoule; 2.5 mg/ml (methylsulfate) in 1 ml ampoule.","Tablet: 15 mg (bromide)."],"facilities":"S,T","path":["19. MUSCLE RELAXANTS (PERIPHERALLY- ACTING) AND CHOLINESTERASE INHIBITORS"]},{"id":268,"name":"Suxamethonium","formulations":["Injection: 50 mg/ml (chloride) in 2 ml ampoule.","Powder for injection: (chloride), in vial."],"facilities":"S,T","path":["19. MUSCLE RELAXANTS (PERIPHERALLY- ACTING) AND CHOLINESTERASE INHIBITORS"]},{"id":269,"name":"Acyclovir","formulations":["Ointment: 3% w/w."],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.1 Anti-infective agents"]},{"id":270,"name":"Gentamicin","formulations":["Solution (eye drops): 0.3% (sulfate)."],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.1 Anti-infective agents"]},{"id":271,"name":"Moxifloxacin","formulations":["Solution (eye drops): 0.3%."],"facilities":"P (Except CC),S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.1 Anti-infective agents"]},{"id":272,"name":"Natamycin","formulations":["Suspension (eye drops): 5%"],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.1 Anti-infective agents"]},{"id":273,"name":"Prednisolone","formulations":["Solution (eye drops): 0.5% (sodium phosphate)."],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.2 Anti-inflammatory agents"]},{"id":274,"name":"Tetracaine","formulations":["Solution (eye drops): 0.5% (hydrochloride)."],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.3 Local anaesthetics"]},{"id":275,"name":"Acetazolamide","formulations":["Tablet: 250 mg."],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.4 Miotics and antiglaucoma medicines"]},{"id":276,"name":"Pilocarpine","formulations":["Solution (eye drops): 2% (hydrochloride or nitrate)."],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.4 Miotics and antiglaucoma medicines"]},{"id":277,"name":"Timolol","formulations":["Solution (eye drops): 0.5% (as hydrogen maleate)."],"facilities":"S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.4 Miotics and antiglaucoma medicines"]},{"id":278,"name":"Atropine","formulations":["Solution (eye drops):1% (sulfate)."],"facilities":"P,S,T","path":["20. OPHTHALMOLOGICAL PREPARATIONS","20.5 Mydriatics"]},{"id":279,"name":"Ethinylestradiol + Levonorgestrel","formulations":["Tablet: 30 micrograms + 150 micrograms."],"facilities":"P,S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.1 Oral hormonal contraceptives"]},{"id":280,"name":"Ethinylestradiol + Norethisterone","formulations":["Tablet: 35 micrograms + 1 mg."],"facilities":"P,S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.1 Oral hormonal contraceptives"]},{"id":281,"name":"Levonorgestrel","formulations":["Tablet: 30 micrograms; 750 micrograms (pack of two); 1.5 mg."],"facilities":"P,S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.1 Oral hormonal contraceptives"]},{"id":282,"name":"Progesterone Only Pill (progestin)","formulations":["Tablet: 0.075 mg"],"facilities":"P,S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.1 Oral hormonal contraceptives"]},{"id":283,"name":"Medroxyprogesterone acetate","formulations":["Injection (intramuscular): 150 mg ml in 1 ml vial.","Injection (subcutaneous): 104 mg/0.65 ml in pre-filled syringe or single-dose injection delivery system."],"facilities":"P,S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.2 Injectable hormonal contraceptives"]},{"id":284,"name":"Copper-containing device","formulations":[],"facilities":"P,S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.3 Intrauterine devices"]},{"id":285,"name":"Levonorgestrel -releasing intrauterine system","formulations":["Intrauterine system: with reservoir containing 52 mg of levonorestrel"],"facilities":"P,S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.3 Intrauterine devices"]},{"id":286,"name":"Etonogestrel-releasing implant","formulations":["Single-rod etonogestrel-releasing implant: containing 68 mg of etonogestrel."],"facilities":"S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.4 Implantable contraceptives"]},{"id":287,"name":"Levonorgestrel-releasing implant","formulations":["Two-rod levonorgestrel-releasing implant: each rod containing 75 mg of levonorgestrel (150 mg total)."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.1 Contraceptives","21.1.4 Implantable contraceptives"]},{"id":288,"name":"Clomifene","formulations":["Tablet: 50 mg"],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.2 Ovulation inducers"]},{"id":289,"name":"Letrozole","formulations":["Tablet: 2.5 mg."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.2 Ovulation inducers"]},{"id":290,"name":"Carbetocin","formulations":["Injection: 100 micrograms in 1 ml ampoule."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.3 Uterotonics"]},{"id":291,"name":"Ergometrine","formulations":["Injection: 200 micrograms (hydrogen maleate) in 1 ml ampoule."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.3 Uterotonics"]},{"id":292,"name":"Mifepristone - Misoprostol","formulations":["Tablet: 200mg + 200mcg"],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.3 Uterotonics"]},{"id":293,"name":"Misoprostol","formulations":["Tablet: 200 micrograms.","Vaginal tablet: 25 micrograms."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.3 Uterotonics"]},{"id":294,"name":"Oxytocin","formulations":["Injection: 10 IU in 1 ml."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.3 Uterotonics"]},{"id":295,"name":"Magnesium Sulphate","formulations":["Injection: 6 mg/ml"],"facilities":"S, T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.4 Antioxytocics (tocolytics)"]},{"id":296,"name":"Nifedipine","formulations":["Immediate-release capsule: 10 mg."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.4 Antioxytocics (tocolytics)"]},{"id":297,"name":"Labetalol","formulations":["Tablet: 100mg, 200mg","Injection: 50 mg/10 ml"],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.5 Other medicines administered to the mother"]},{"id":298,"name":"Methyldopa","formulations":["Tablet: 250 mg."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.5 Other medicines administered to the mother"]},{"id":299,"name":"Dexamethasone","formulations":["Injection: 4 mg/ml dexamethasone phosphate (as sodium phosphate) (equivalent to 3.3 mg/ml dexamethasone base) in 1 ml ampoule."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.5 Other medicines administered to the mother"]},{"id":300,"name":"Multiple Micronutrient Supplement","formulations":["Tablet: 15mg"],"facilities":"P,S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.5 Other medicines administered to the mother"]},{"id":301,"name":"Tranexamic acid","formulations":["Injection: 100 mg/ml in 10 ml ampoule."],"facilities":"S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.5 Other medicines administered to the mother"]},{"id":302,"name":"Chlorhexidine","formulations":["Solution or gel: 7.1% (digluconate) delivering 4% chlorhexidine (for umbilical cord care)."],"facilities":"P, S,T","path":["21. MEDICINES FOR REPRODUCTIVE HEALTH AND PERINATAL CARE","21.6 Medicines administered to the neonate"]},{"id":303,"name":"Intraperitoneal dialysis solution","formulations":["Solution of appropriate composition in accordance with local clinical guidelines."],"facilities":"T","path":["22. PERITONEAL DIALYSIS SOLUTION"]},{"id":304,"name":"Chlorpromazine","formulations":["Tablet: 50 mg; 100 mg.","Injection: 1 ampoule equivalent 50mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.1 Medicines for psychotic disorders"]},{"id":305,"name":"Fluphenazine","formulations":["Injection: 25 mg/ml (decanoate or enantate) in 1 ml ampoule."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.1 Medicines for psychotic disorders"]},{"id":306,"name":"Haloperidol","formulations":["Tablet: 5 mg.","Injection: 5 mg/ml in 1 ml ampoule."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.1 Medicines for psychotic disorders"]},{"id":307,"name":"Olanzapine","formulations":["Tablet: 5 mg, 10mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.1 Medicines for psychotic disorders"]},{"id":308,"name":"Procyclidine","formulations":["Tablet: 5mg","Injection: 10 mg/2ml"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.1 Medicines for psychotic disorders"]},{"id":309,"name":"Risperidone","formulations":["Tablet: 1mg, 2mg, 4mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.1 Medicines for psychotic disorders"]},{"id":310,"name":"Amitriptyline","formulations":["Tablet: 10 mg, 25 mg (hydrochloride)."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.1 Medicines for depressive disorders"]},{"id":311,"name":"Clonazepam","formulations":["Tablet: 0.5 mg, 1 mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.1 Medicines for depressive disorders"]},{"id":312,"name":"Fluoxetine","formulations":["Tablet: 20 mg (as hydrochloride)."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.1 Medicines for depressive disorders"]},{"id":313,"name":"Nortriptyline","formulations":["Tablet: 10 mg, 25 mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.1 Medicines for depressive disorders"]},{"id":314,"name":"Sertraline","formulations":["Tablet: 25 mg, 50mg (as hydrochloride)."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.1 Medicines for depressive disorders"]},{"id":315,"name":"Lithium Carbonate","formulations":["Tablet: 400 mg."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.2 Medicines for bipolar disorders"]},{"id":316,"name":"Lamotrigine","formulations":["Tablet: 25 mg, 50 mg, 100 mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.2 Medicines for bipolar disorders"]},{"id":317,"name":"Sodium Valproate (Valproic acid)","formulations":["Tablet (enteric-coated): 200 mg; 500 mg."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.2 Medicines for mood disorders","23.2.2 Medicines for bipolar disorders"]},{"id":318,"name":"Amitriptyline","formulations":["Tablet: 10 mg, 25 mg"],"facilities":"P (Except cc),S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.3 Medicines for anxiety disorders"]},{"id":319,"name":"Diazepam","formulations":["Tablet (scored): 5 mg."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.3 Medicines for anxiety disorders"]},{"id":320,"name":"Fluoxetine","formulations":["Capsule: 20 mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.3 Medicines for anxiety disorders"]},{"id":321,"name":"Sertraline","formulations":["Tablet: 25 mg, 50 mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.3 Medicines for anxiety disorders"]},{"id":322,"name":"Fluoxetine","formulations":["Capsule: 20mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.4 Medicines for obsessive compulsive disorders"]},{"id":323,"name":"Sertraline","formulations":["Tablet: 25 mg, 50mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.4 Medicines for obsessive compulsive disorders"]},{"id":324,"name":"Bupropion","formulations":["Tablet (sustained-release): 150 mg (hydrochloride)."],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.5 Medicines for disorders due to psychoactive substance use","23.5.1 Medicines for nicotine use disorders"]},{"id":325,"name":"Nicotine replacement therapy (NRT)","formulations":["Chewing gum: 2 mg; 4 mg","Lozenge: 2 mg; 4 mg."],"facilities":"T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.5 Medicines for disorders due to psychoactive substance use","23.5.1 Medicines for nicotine use disorders"]},{"id":326,"name":"Atomoxetine","formulations":["Capsule: 10 mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.5 Medicines for disorders due to psychoactive substance use","23.5.2 Medicines for children and adolescent mental disorders (Attention Deficit Hyperactivity Disorder)"]},{"id":327,"name":"Methylphenidate","formulations":["Tablet: 10mg"],"facilities":"S,T","path":["23. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS","23.5 Medicines for disorders due to psychoactive substance use","23.5.2 Medicines for children and adolescent mental disorders (Attention Deficit Hyperactivity Disorder)"]},{"id":328,"name":"Beclomethasone","formulations":["Powder for inhalation: 50 micrograms per actuation; 100 micrograms per actuation; 250 micrograms per actuation in dry powder inhaler."],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":329,"name":"Budesonide","formulations":["Powder for inhalation: 100 micrograms per actuation; 200 micrograms per actuation in dry powder inhaler.","Suspension for inhalation: 100 micrograms per actuation; 200 micrograms per actuation in pressurized metered-dose inhaler."],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":330,"name":"Budesonide+formoterol","formulations":["Powder for inhalation: 100 micrograms + 6 micrograms per actuation; 200 micrograms + 6 micrograms per actuation in dry powder inhaler."],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":331,"name":"Epinephrine (Adrenaline)","formulations":["Injection: 1 mg/ml (as hydrochloride or hydrogen tartrate) in 1 ml ampoule."],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":332,"name":"Fluticasone","formulations":["Inhaler: 125 micrograms per dose; 250 micrograms per dose."],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":333,"name":"Hydrocortisone","formulations":["Tablet: 10 mg, 20 mg","Injection: 100 mg/vial"],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":334,"name":"Ipratropium bromide","formulations":["Inhalation (aerosol): 20 micrograms/metered dose."],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":335,"name":"Montelukast","formulations":["Tablet: 5mg, 10 mg Chewable Tablet: 4 mg, 5 mg, 10mg"],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":336,"name":"Oxygen","formulations":[],"facilities":"P,S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":337,"name":"Prednisolone","formulations":["Tablet: 5 mg, 10 mg, 20 mg","Oral Solution: 5 mg/5 ml"],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":338,"name":"Salbutamol","formulations":["Injection: 05mg/ml, 5 mg/5 ml.","Dry Powder for inhalation: 200 micrograms per actuation in pressurized metered-dose inhaler;","Nebulizer solution: 2.5 mg/3 ml; 5 mg/2.5 ml; 5 mg/ml in multi-dose bottle for use in nebulizers.","Syrup: 2mg/5ml","Tablet: 2mg, 4mg"],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":339,"name":"Tiotropium","formulations":["Powder for inhalaton: 18 micrograms in capsule."],"facilities":"S,T","path":["24. MEDICINES ACTING ON THE RESPIRATORY TRACT","24.1 Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease"]},{"id":340,"name":"Oral Rehydration Salts (ORS)","formulations":[],"facilities":"P,S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.1 Oral"]},{"id":341,"name":"Potassium chloride","formulations":[],"facilities":"P,S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.1 Oral"]},{"id":342,"name":"Calcium Gluconate","formulations":["Injection: 100 mg/ml"],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":343,"name":"Cholera Fluid","formulations":["IV Infusion"],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":344,"name":"Ringers lactate","formulations":["Injectable solution"],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":345,"name":"Dextran","formulations":["Injection"],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":346,"name":"Dextrose in Water","formulations":["IV Infusion: 5% w/v (500 ml, 1000 ml); 10% w/v (500 ml); 25% w/v (500 ml)"],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":347,"name":"Glucose","formulations":["Injectable solution: 5% (isotonic); 10% (hypertonic); 50% (hypertonic)."],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":348,"name":"Glucose with sodium chloride","formulations":["Injectable solution: 4% glucose, 0.18% sodium chloride (equivalent to Na+ 30 mmol/L, Cl– 30 mmol/L).","Injectable solution: 5% glucose, 0.9% sodium chloride (equivalent to Na+ 150 mmol/L and Cl– 150 mmol/L)"],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":349,"name":"Potassium chloride","formulations":["Solution: 11.2% in 20 ml ampoule (equivalent to K+ 1.5 mmol/ml, Cl– 1.5 mmol/ml)."],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":350,"name":"Sodium chloride","formulations":["Injectable solution: 0.9% isotonic (equivalent to Na+ 154 mmol/L, Cl– 154 mmol/L)."],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.2 Parenteral"]},{"id":351,"name":"Water for Injection (sterile/pyrogen free)","formulations":["Injection: 3 ml; 5 ml"],"facilities":"S,T","path":["25. SOLUTIONS CORRECTING WATER, ELECTROLYTE & ACID- BASE DISTURBANCES","25.3 Miscellaneous"]},{"id":352,"name":"Ascorbic Acid (Vitamin C)","formulations":["Tablet: 50 mg."],"facilities":"P,S,T","path":["26. VITAMINS AND MINERALS"]},{"id":353,"name":"Cholecalciferol (Vitamin D3)","formulations":["Oral liquid: 400 IU/ml.","Tablet: 400 IU; 1000 IU."],"facilities":"S,T","path":["26. VITAMINS AND MINERALS"]},{"id":354,"name":"Folic Acid (Vitamin B9)","formulations":["Tablet: 5 mg"],"facilities":"P,S,T","path":["26. VITAMINS AND MINERALS"]},{"id":355,"name":"Iodine","formulations":["Capsule: 190 mg.","Iodized oil: 1 mL (480 mg iodine); 0.5 mL (240 mg iodine) in ampoule (oral or injectable); 0.57 mL (308 mg iodine) in dispenser bottle."],"facilities":"P,S,T","path":["26. VITAMINS AND MINERALS"]},{"id":356,"name":"Phytomenadione (Vitamin K)","formulations":["Injection: 1 mg/ml; 10 mg/ml in ampoule.","Tablet: 10 mg."],"facilities":"S,T","path":["26. VITAMINS AND MINERALS"]},{"id":357,"name":"Pyridoxine (Vitamin B6)","formulations":["Tablet: 20 mg"],"facilities":"S,T","path":["26. VITAMINS AND MINERALS"]},{"id":358,"name":"Retinol (Vitamin A)","formulations":["Capsule: 50 000 IU; 100 000 IU; 200 000 IU (as palmitate).","Oral oily solution: 100 000 IU/ml (as palmitate) in multidose dispenser.","Tablet (sugar-coated): 10 000 IU (as palmitate).","Water-miscible injection: 100 000 IU (as palmitate) in 2 ml ampoule."],"facilities":"P,S,T","path":["26. VITAMINS AND MINERALS"]},{"id":359,"name":"Budesonide","formulations":["Nasal spray: 100 mcg/spray"],"facilities":"S,T","path":["27. EAR, NOSE AND THROAT MEDICINES"]},{"id":360,"name":"Ciprofloxacin","formulations":["Solution (ear drops): 0.3%"],"facilities":"S,T","path":["27. EAR, NOSE AND THROAT MEDICINES"]},{"id":361,"name":"Clotrimazole","formulations":["Ear Drops: 1% w/v"],"facilities":"P(Except CC), S,T","path":["27. EAR, NOSE AND THROAT MEDICINES"]},{"id":362,"name":"Xylometazoline","formulations":["Nasal spray: 0.05%,0.1%","Nasal drop: 0.05%, 0.1%"],"facilities":"P(Except CC), S,T","path":["27. EAR, NOSE AND THROAT MEDICINES"]},{"id":363,"name":"Allopurinol","formulations":["Tablet: 100 mg, 300mg"],"facilities":"S,T","path":["28. MEDICINES FOR DISEASES OF JOINTS","28.1 Medicines used to treat gout"]},{"id":364,"name":"Chloroquine","formulations":["Tablet: 250 mg","Syrup: 50mg/5ml, 80mg/5ml"],"facilities":"S,T","path":["28. MEDICINES FOR DISEASES OF JOINTS","28.2 Disease-modifying anti-rheumatic drugs (DMARDs)"]},{"id":365,"name":"Hydroxychloroquine","formulations":["Tablet: 200 mg , 400mg"],"facilities":"S,T","path":["28. MEDICINES FOR DISEASES OF JOINTS","28.2 Disease-modifying anti-rheumatic drugs (DMARDs)"]},{"id":366,"name":"Methotrexate","formulations":["Tablet: 2.5mg, 10 mg , 15 mg","Injection: 25mg/ml"],"facilities":"S,T","path":["28. MEDICINES FOR DISEASES OF JOINTS","28.2 Disease-modifying anti-rheumatic drugs (DMARDs)"]},{"id":367,"name":"Sulfasalazine","formulations":["Tablet: 500 mg.","Suppository: 500 mg."],"facilities":"S,T","path":["28. MEDICINES FOR DISEASES OF JOINTS","28.2 Disease-modifying anti-rheumatic drugs (DMARDs)"]},{"id":368,"name":"Diclofenac","formulations":["Tablet: 25 mg, 50 mg."],"facilities":"S,T","path":["29. DENTAL MEDICINES AND PREPARATIONS"]}],"uniqueNames":296,"alphabeticalNames":["Abacavir (ABC)","Abacavir + Dolutegravir + Lamivudine","Abacavir + lamivudine","ACD Blood Pack/Double Bag/Triple Bag","Acetazolamide","Acetylsalicylic Acid (Aspirin)","Acyclovir","Albendazole","Albumin","Alcohol based hand rub","Allopurinol","Aluminium Hydroxide + Magnesium Hydroxide","Amikacin","Amiodarone","Amitriptyline","Amlodipine","Amoxicillin","Amoxicillin + clavulanic acid","Amphotericin B","Anastrozole","Anti-D immunoglobulin","Anti-rabies immunoglobulin","Anti-tetanus immunoglobulin","Antivenom immunoglobulin","Artemether + Lumefantrine","Artesunate","Ascorbic Acid (Vitamin C)","Asparaginase / Crisantaspase/ L-asparaginase","Atenolol","Atomoxetine","Atorvastatin","Atracurium","Atropine","Azathioprine","Azithromycin","Barium Sulphate (X-Ray Grade)","BCG Vaccine","Beclomethasone","Bedaquiline","Benzathine benzylpenicillin","Benzyl Benzoate","Betamethasone","Bicalutamide","Bisacodyl","Bisoprolol","Bleomycin","bOPV Vaccine","Budesonide","Budesonide+formoterol","Bupivacaine","Bupropion","Calamine","Calcium folinate (leucovorin calcium)","Calcium Gluconate","Capecitabine","Carbamazepine","Carbetocin","Carbimazole","Carboplatin","Cefalexin","Cefixime","Cefradine","Ceftazidime","Ceftriaxone","Cefuroxime","Chlorhexidine","Chloroquine","Chloroxylenol","Chlorpheniramine","Chlorpromazine","Cholecalciferol (Vitamin D3)","Cholera Fluid","Cholera Vaccine","Ciprofloxacin","Cisplatin","Clarithromycin","Clindamycin","Clofazimine","Clomifene","Clonazepam","Clopidogrel","Clotrimazole","Cloxacillin","Coagulation Factor IX","Coagulation Factor VIII","Copper-containing device","Cyclophosphamide","Cycloserine","Dactinomycin / Actinomycin D","Dapsone","Deferoxamine","Delamanid","Dexamethasone","Dextran","Dextrose in Water","Diazepam","Diclofenac","Digoxin","Diphtheria antitoxin","Docetaxel","Dolutegravir","Dolutegravir + lamivudine + tenofovir","Domperidone","Doxorubicin","Doxycycline","Efavirenz + lamivudine + tenofovir","Empagliflozin","Enalapril","Enoxaparin","Ephedrine","Epinephrine (Adrenaline)","Ergometrine","Erlotinib","Ethambutol + Isoniazid + Pyrazinamide + Rifampicin (4FDC)","Ethinylestradiol + Levonorgestrel","Ethinylestradiol + Norethisterone","Ethionamide","Etonogestrel-releasing implant","Etoposide","Famotidine","Fentanyl","Ferrous salt","Ferrous salt + Folic Acid","Fexofenadine","Filgrastim","Flucloxacillin","Fluconazole","Fluorescein","Fluorouracil","Fluoxetine","Fluphenazine","Fluticasone","Folic Acid (Vitamin B9)","Furosemide","Gadoterate meglumine","Gefitinib","Gemcitabine","Gentamicin","Gliclazide","Glucose","Glucose with sodium chloride","Glycerin/Glycerol","Glyceryl Trinitrate (Nitroglycerin)","Haloperidol","Heparin sodium","Hepatitis B Vaccine","Human Papilloma Virus (HPV) Vaccine","Hydrochlorothiazide","Hydrocortisone","Hydroxocobalamin","Hydroxychloroquine","Hyoscine butylbromide","Ibuprofen","Ifosfamide","Imatinib","Influenza vaccine (seasonal)","Insulin injection (soluble)","Intermediate-acting insulin","Intraperitoneal dialysis solution","Iodine","Iohexol","Ipratropium bromide","Isoflurane","Isoniazid","Isoniazid + Rifampicin (2FDC)","Isoniazid + Rifapentine (3HP)","Itraconazole","Ivermectin","Ketamine","Labetalol","Lactulose","Lamivudine (3TC)","Lamotrigine","Letrozole","Levodopa + carbidopa","Levofloxacin","Levonorgestrel","Levonorgestrel -releasing intrauterine system","Levonorgestrel-releasing implant","Levothyroxine","Lidocaine","Lidocaine + Epinephrine (adrenaline)","Linezolid","Lithium Carbonate","Lopinavir + ritonavir","Losartan","Magnesium Sulphate","Mebendazole","Medroxyprogesterone acetate","Melphalan","Mercaptopurine","Meropenem","Metformin","Methotrexate","Methyldopa","Methylphenidate","Methylprednisolone","Metoprolol","Metronidazole","Miconazole","Midazolam","Mifepristone - Misoprostol","Misoprostol","Montelukast","Morphine","Moxifloxacin","MR Vaccine (Measles & Rubella)","Multiple Micronutrient Supplement","Naloxone","Natamycin","Neostigmine","Nicotine replacement therapy (NRT)","Nifedipine","Nitrofurantoin","Nitrous Oxide","Nor-adrenaline (Norepinephrine)","Norethisterone acetate","Nortriptyline","Nystatin","Olanzapine","Omeprazole","Ondansetron","Oral Rehydration Salts (ORS)","Oxaliplatin","Oxygen","Oxytocin","Paclitaxel","Paracetamol (acetaminophen)","Pentavalent vaccine (DPT, HepatitisB , Hib)","Permethrin","Pethidine","Phenobarbital","Phenoxymethylpenicillin","Phenytoin","Phytomenadione (Vitamin K)","Pilocarpine","Piperacillin + Tazobactam","Pneumococcal Vaccine","Poliomyelitis Vaccine","Potassium chloride","Potassium Permanganate","Povidone Iodine","Pralidoxime","Prednisolone","Premixed insulin (30/70)","Pretomanid","Primaquine","Procyclidine","Progesterone Only Pill (progestin)","Propranolol","Prothionamide","Pyridoxine (Vitamin B6)","Retinol (Vitamin A)","Rifampicin","Rifapentine","Ringers lactate","Risperidone","Rituximab -including quality-assured biosimilars","Rivaroxaban","Salbutamol","Salicylic acid","Sertraline","Silver sulfadiazine","Sodium chloride","Sodium Valproate (Valproic acid)","Sofosbuvir + velpatasvir","Spironolactone","Streptokinase","Sulfamethoxazole + Trimethoprim","Sulfasalazine","Suxamethonium","Tamoxifen","TD Vaccine (Tetanus and Diphtheria)","Telmisartan + Amlodipine","Telmisartan + Hydrochlorothiazide","Tenofovir disoproxil fumarate (TDF)","Tetanus Vaccine","Tetracaine","Thiopental","Timolol","Tiotropium","Tramadol","Tranexamic acid","Trastuzumab -including quality-assured biosimilars","Tropicamide","Tuberculin, purified protein derivative (PPD)","Typhoid Conjugate Vaccine","Vancomycin","Vecuronium","Verapamil","Vinblastine","Vincristine","Water for Injection (sterile/pyrogen free)","Xylometazoline","Zidovudine (ZDV or AZT)","Zinc sulfate"],"policy":{"overview":[{"type":"heading","text":"দুইটি প্রজ্ঞাপন"},{"type":"subheading","text":"১. ঔষধের মূল্য নির্ধারণ পদ্ধতি ২০২৬ (অ্যালোপ্যাথিক)"},{"type":"paragraph","text":"নং ৪৫.০০.০০০০,১৮২.০৬.০০২,২১.৩২ — তারিখ: ০৮ মাঘ ১৪৩২/২২ জানুয়ারি ২০২৬। সরকার ঔষধ ও কসমেটিকস্ আইন, ২০২৩ এর ধারা ৩০ এ প্রদত্ত ক্ষমতাবলে ঔষধের মূল্য নির্ধারণ পদ্ধতি ২০২৬ জারি করিল।"},{"type":"subheading","text":"২. অত্যাবশ্যকীয় ঔষধ তালিকা ২০২৬ (অ্যালোপ্যাথিক)"},{"type":"paragraph","text":"নং ৪৫.০০.০০০০.১৮২.০৬.০০২.২১.৩৩ — তারিখ: ০৮ মাঘ ১৪৩২/২২ জানুয়ারি ২০২৬। জাতীয় ঔষধ নীতি ২০১৬-এর পরিশিষ্ট ১ এ উল্লিখিত “অত্যাবশ্যকীয় ঔষধের তালিকা (অ্যালোপ্যাথিক)” প্রতিস্থাপন করে “অত্যাবশ্যকীয় ঔষধের তালিকা (অ্যালোপ্যাথিক) ২০২৬” প্রণয়ন ও কার্যকর করা হলো।"},{"type":"heading","text":"পটভূমি: ১৯৮২ থেকে ২০২৬"},{"type":"timeline","label":"১৯৮২","text":"জাতীয় ঔষধ নীতি ও ঔষধ নিয়ন্ত্রণ অধ্যাদেশ, ১৯৮২ — ‘অত্যাবশ্যকীয় ঔষধ’ ধারণার কাঠামোগত রূপ; ১১ ধারায় সকল ঔষধের মূল্য নির্ধারণের অধিকার সরকারের কাছে সংরক্ষিত।"},{"type":"timeline","label":"১৯৮৫","text":"বিজ্ঞানসম্মত, কাঠামোবদ্ধ ও সুনির্দিষ্ট মূল্য নির্ধারণ পদ্ধতি প্রবর্তন — প্রথম এক দশকে ঔষধ শিল্পের সর্বোচ্চ বিকাশ ও স্বনির্ভরতা অর্জন।"},{"type":"timeline","label":"১৯৯৪","text":"স্বাস্থ্য মন্ত্রণালয়ের আদেশে সরকারের মূল্য নির্ধারণ ক্ষমতা সংকুচিত — কেবল ১১৭টি ‘বহুল ব্যবহৃত প্রয়োজনীয় ঔষধ’-এ সীমাবদ্ধ।"},{"type":"timeline","label":"২০১৬","text":"জাতীয় ঔষধ নীতি ২০১৬ — ‘অত্যাবশ্যকীয় ঔষধের তালিকা (অ্যালোপ্যাথিক)’ পরিশিষ্ট-০১ হিসেবে অন্তর্ভুক্ত।"},{"type":"timeline","label":"২০২৩","text":"ঔষধ নিয়ন্ত্রণ অধ্যাদেশ, ১৯৮২ রহিত করে ঔষধ ও কসমেটিকস আইন, ২০২৩ প্রণয়ন — মূল্য নির্ধারণের পরিধি বিস্তৃত (ধারা ৩০)।"},{"type":"timeline","label":"০৭ নভেম্বর ২০২৪","text":"উপদেষ্টা পরিষদের সভা — তালিকা প্রণয়ন সময়োপযোগী, তবে উচ্চ পর্যায়ের টাস্কফোর্স কর্তৃক পুনঃপর্যালোচনার সিদ্ধান্ত।"},{"type":"timeline","label":"২০২৫","text":"মহামান্য হাইকোর্ট বিভাগের রায় (Writ Petition No. 10080 of 2018) — মূল্য নির্ধারণ রাষ্ট্রের অর্পণযোগ্য নয় (Non-delegable) দায়িত্ব।"},{"type":"timeline","label":"২৪ জুলাই ২০২৫","text":"টাস্কফোর্স গঠন (১৮ সদস্য) — প্রতিবেদন দাখিলের সময়সীমা ২০ আগস্ট ২০২৫।"},{"type":"timeline","label":"২১ সেপ্টেম্বর ২০২৫","text":"টাস্কফোর্স সভা — মূল্য নির্ধারণের জন্য সাব কমিটি গঠনের সিদ্ধান্ত।"},{"type":"timeline","label":"২৮ সেপ্টেম্বর ২০২৫","text":"মূল্য নির্ধারণ সাব কমিটি গঠন (৮ সদস্য)।"},{"type":"timeline","label":"২২ জানুয়ারি ২০২৬","text":"দুইটি প্রজ্ঞাপন জারি — মূল্য নির্ধারণ পদ্ধতি ২০২৬ এবং অত্যাবশ্যকীয় ঔষধ তালিকা ২০২৬।"},{"type":"timeline","label":"২৯ জানুয়ারি ২০২৬","text":"বাংলাদেশ গেজেটে প্রকাশিত (১ম খণ্ড, পৃষ্ঠা ৫৭–৯১)।"},{"type":"heading","text":"মূল্য নির্ধারণের শ্রেণিবিন্যাস"},{"type":"paragraph","text":"কার্যকর ব্যবস্থাপনা ও প্রয়োগের সুবিধার্থে সকল ঔষধকে তিনটি প্রধান শ্রেণিতে বিন্যস্ত করা হয়েছে:"},{"type":"table","rows":[["প্রধান শ্রেণি","উপ-বিভাগ","মূল্য নির্ধারণ পদ্ধতি"],["ক. বর্তমানে অনুমোদনপ্রাপ্ত ঔষধ","অত্যাবশ্যকীয়","কস্ট-প্লাস বেঞ্চমার্কিং (শ্রেণিভিত্তিক মার্কআপ)"],["অন্যান্য","অভ্যন্তরীণ রেফারেন্স মূল্য; ৭-এর কম উৎপাদক হলে আন্তর্জাতিক রেফারেন্স মূল্যের সমান্তরাল যাচাই — যেটি নিম্নতর"],["খ. ভবিষ্যতে অনুমোদন লাভকারী ঔষধ","পেটেন্ট-বহির্ভুত (নতুন জেনেরিক)","কস্ট-প্লাস × ১.৩৩ প্রণোদনাসূচক মার্কআপ"],["পেটেন্ট-ভুক্ত","আন্তর্জাতিক রেফারেন্স মূল্য (PPP সমন্বিত), মধ্যক বেঞ্চমার্কের সমান বা নিচে"],["গ. বায়োলজিক্যাল ও ইমিউনোলজিক্যাল","—","উৎপাদন ব্যয়ের বস্তুনিষ্ঠ মূল্যায়ন + ‘অগ্রাধিকারপ্রাপ্ত খাত’ মুনাফা মার্জিন"]]},{"type":"paragraph","text":"এছাড়া আমদানিকৃত ফিনিশড প্রোডাক্টের সর্বোচ্চ খুচরা মূল্য বিদ্যমান মার্কআপ অনুসারে নির্ধারিত হবে।"}],"pricing":[{"type":"heading","text":"১. প্রস্তাবনা"},{"type":"clause","label":"১.১","text":"বাংলাদেশ সরকার ঔষধকে জনকল্যাণকর রাষ্ট্র গঠনের একটি মৌলিক উপাদান হিসেবে বিবেচনা করে। কার্যকর ও নিরাপদ ঔষধের প্রাপ্যতা জনগণের স্বাস্থ্য অধিকারের একটি অবিচ্ছেদ্য অংশ এবং সামাজিক ন্যায়বিচার প্রতিষ্ঠা ও জাতীয় উন্নয়নের জন্য অপরিহার্য শর্ত। সরকার জনস্বার্থে ঔষধের বাজার তদারকি করছে এবং দেশীয় ঔষধ শিল্পের সক্ষমতা বৃদ্ধি ও বিকাশে নীতিগত সহায়তা প্রদান করে আসছে।"},{"type":"clause","label":"১.২","text":"বাংলাদেশের ঔষধ খাতের ইতিহাসে ১৯৮২’র জাতীয় ঔষধ নীতি একটি ঐতিহাসিক মাইলফলক, যা বিশ্বব্যাপি ব্যাপকভাবে প্রশংসিত হয়। এই নীতির আলোকে সরকার ঔষধ নিয়ন্ত্রণ অধ্যাদেশ, ১৯৮২ [The Drugs (Control) Ordinance, 1982] জারি করে। এই যুগন্তকারী পদক্ষেপের মাধ্যমেই দেশে ‘অত্যাবশ্যকীয় ঔষধ’ এর ধারণা একটি কাঠামোগত রূপ পায়। অপচয় এবং জনস্বাস্থ্যের ঝুঁকি বিবেচনায় নিয়ে সকল প্রকার অপ্রয়োজনীয়, ঝুঁকিপুর্ণ, অপ্রমাণিত কার্যকারিতারসম্পন্ন, অযৌক্তিক ফর্মুলেশনের ঔষধ নিষিদ্ধ করা ছিল এই অধ্যাদেশের অন্যতম প্রধান বৈশিষ্ট্য। একই সাথে দেশীয় ঔষধ শিল্প বিকাশের উদ্দেশ্যে যে সকল ঔষধ দেশে যথেষ্ট উৎপাদিত হয়, সেগুলোর আমদানী নিষিদ্ধ করা হয়। ছাড়াও বহুজাতিক প্রতিষ্ঠানসমূহকে সহজ প্রযুক্তির ঔষধ উৎপাদনে নিরুৎসাহিত করা হয় এবং দেশে কারখানা স্থাপনের বাধ্যবাধকতা আরোপ করা হয়।"},{"type":"clause","label":"১.৩","text":"এখানে উল্লেখ্য যে জাতীয় ঔষধ নীতিতে সাধারণ মানুষের প্রয়োজনের মুহুর্তে ঔষধের প্রাপ্যতা নিশ্চিত করার লক্ষ্যে ঔষধ উৎপাদনের দেশীয় সামর্থ্যকে ব্যবহার করার পাশাপাশি ঔষধের মূল্য নিয়ন্ত্রণের নির্দেশনা ছিল। ঔষধ নিয়ন্ত্রণ অধ্যাদেশ ১৯৮২, এর ১১ ধারায় সকল ঔষধের মূল্য নির্ধারণ করার অধিকার সরকার কর্তৃক সংরক্ষিত ছিল। এর ধারাবাহিকতায় ১৯৮৫ সালে ঔষধ শিল্পের বিকাশের জন্য প্রয়োজনীয় ও যৌক্তিক মুনাফার সুযোগ রেখে একটি বিজ্ঞানসম্মত, কাঠামোবদ্ধ ও সুনির্দিষ্ট মূল্য নির্ধারণ পদ্ধতি প্রবর্তনের প্রথম এক দশকে বাংলাদেশের ঔষধ শিল্পের সর্বোচ্চ বিকাশ সাধিত হয় এবং দেশ ঔষধখাতে স্বনির্ভরতা অর্জনে সক্ষম হয়। এই দূরদর্শী নীতি বাস্তবায়নের ফলে ঔষধের প্রাপ্যতা উল্লেখযোগ্যভাবে বৃদ্ধি পেয়েছে এবং বর্তমানে দেশীয় ঔষধ শিল্প জাতীয় চাহিদার সিংহভাগ পূরণ করতে সক্ষম।"},{"type":"clause","label":"১.৪","text":"জাতীয় ঔষধ নীতি, ১৯৮২ প্রনয়ণের প্রায় এক যুগ পরে, ১৯৯৪ সালে স্বাস্থ্য মন্ত্রণালয় একটি আদেশ জারির মাধ্যমে ঔষধের মূল্য নির্ধারণ করার ক্ষেত্রে সরকারের ক্ষমতার পরিধি সংকুচিত করে। এর ফলে সেরকারের মূল্য নির্ধারণ ক্ষমতা কেবল “বহুল ব্যবহৃত প্রয়োজনীয় ঔষধ” হিসেবে তালিকাভুক্ত ১১৭টি ঔষধের মধ্যে সীমাবদ্ধ হয়ে পড়ে। ফলে সে সময়ের ঔষধ বাজারের প্রায় দুই-তুতীয়াংশ ঔষধের মূল্য নির্ধারণে সরকারের ভুমিকা নেহায়েতই আনুষ্ঠানিকতায় পরিণত হয়। এই পদক্ষেপটি ১৯৮২ সালের ঐতিহাসিক ঔষধ নীতির মূল দর্শনের পরিপন্থী।"},{"type":"clause","label":"১.৫","text":"বিগত কয়েক দশকে বিশ্বব্যাপি চিকিৎসা বিজ্ঞানে অতুত্পূর্ব অগ্রগতির ফলে নিত্যনতুন অনেক ঔষধ আবিস্কৃত হয়েছে। স্বল্লোন্নত দেশ (LDC) হিসেবে বাংলাদেশ TRIPS চুক্তির আওতায় প্রাপ্ত বিশেষ সুবিধা কাজে লাগিয়ে বেশকিছু এধরণের নতুন ঔষধ দেশেই প্রস্তুত করছে। অনেকক্ষেত্রে নতুন এই ঔষধসমূহ কার্যকারিতা ও নিরাপত্তার দিক থেকে বিদ্যমান ঔষধসমূহের তুলনায় উল্লেখযোগ্যতাবে শ্রেয় না হওয়া স্বতেও উচ্চমূল্যের কারণে অধিকতর গৃরুত্ব পাচ্ছে, ফলশুতিতে অত্যাবশ্যকীয়, পরীক্ষিত ও প্রমাণিত ঔষধের ব্যবহার হ্রাস পাচ্ছে। ফলে দেশে সার্বিকভাবে চিকিৎসার জন্য ব্যক্তি পর্যায়ের ব্যয় (Out of Pocket Expenditure) আশংকাজনকভাবে বৃদ্ধি পেয়েছে।"},{"type":"clause","label":"১.৬","text":"একইসময়ে বাংলাদেশে রোগের প্রবণতা পরিবর্তিত হয়েছে, নতুন নতুন অনেক ঔষধ অনুমোদিত হয়েছে এবং চিকিৎসার গাইডলাইন পরিবর্তিত হয়েছে। চিকিৎসাবিজ্ঞানে অ্যালোপ্যাথিক ঔষধসমূহকে সাধারণতঃ মূল্যধারা হিসেবে বিবেচনা করা হয় এবং বিশ্ব স্বাস্থ্য সংস্থাও অত্যাবশ্যকীয় ঔষধ বিষয়ক হিসেবে অ্যালোপ্যাথিক ঔষধসমূহকে প্রাধান্য দিয়ে থাকে। যেহেতু বাংলাদেশের ঔষধের বাজার ও সরবরাহ ব্যবস্থাপনায় অ্যালোপ্যাথিক ঔষধের প্রাধান্য আছে, সেহেতু জাতীয় ঔষধ নীতি, ২০১৬ এর সংযুক্তি আকারে উল্লেখিত ‘অত্যাবশ্যকীয় ঔষধের তালিকা’ এর মধ্যকার অ্যালোপ্যাথিক অংশটি হালানাগাদকরণের উদ্দেশ্যে বাংলাদেশের অন্তর্বর্তী সরকার ২০২৫ সালে একটি উচ্চ ক্ষমতাসম্পন্ন টাস্কফোর্স (সংযুক্তি-১) গঠন করে। গঠিত টাস্কফোর্স এর দায়িত্ব ছিল অত্যাবশ্যকীয় ঔষধের জাতীয় তালিকা এবং সকল ঔষধের জন্য একটি যৌক্তিক মূল্য নির্ধারণ পদ্ধতি প্রণয়ন। টাস্কফোর্স একাধিক সভা এবং সংশ্লিষ্ট অংশীজনদের সাথে আলোচনার ভিত্তিতে ‘অত্যাবশ্যকীয় ঔষধের জাতীয় তালিকা’ এর অ্যালোপ্যাথিক ঔষধসমূহের অংশটুকু হালনাগাদ করেছে।"},{"type":"clause","label":"১.৭","text":"প্রসঙ্গক্রমে উল্লেখ্য যে ২০২৫ সালে মহামান্য হাইকোর্ট বিভাগ কর্তৃক (Writ Petition No. 10080 of 2018) প্রদত্ত রায় স্পষ্টভাবে উল্লেখ করা হয়েছে যে, অত্যাবশ্যকীয় ও জীবনরক্ষকারী ঔষধের মূল্য নির্ধারণ ও তদারকি করা রাষ্ট্রের অর্পণযোগ্য নয় (Non-delegable) এমন একটি সাংবিধানিক ও আইনগত দায়িত্ব। মহামান্য আদালত আরো অভিমত প্রদান করেন যে, ঔষধের মূল্য নির্ধারণে রাষ্ট্রীয় ক্ষমতা কেবল একটি সাধারণ দায়িত্বপালনের বিষয় নয়, ববং এটি জনস্বার্থে অবশ্যপালনযোগ্য কর্তব্য। রায়ে আরও বলা হয়েছে যে, ১৯৯৪ সালের আদেশের মাধ্যমে ঔষধের মূল্য নির্ধারণের সীমানা সংকৃচিত করা এবং তা উৎপাদনকারীদের ওপর হেড়ে দেওয়ার সিদ্ধান্তটি মন্ত্রণালয়ের এখতিয়ার বহির্ভুত এবং একইসাথে জনস্বার্থ পরিপন্থী। এই প্রেক্ষাপটে মহামান্য হাইকোর্ট বিভাগ নির্দেশনা প্রদান করেন যে, অত্যাবশ্যকীয় ও জীবনরক্ষকারী সকল ঔষধের সর্বোচ্চ খুচরা মূল্য সরকারকেই নির্ধারণ করতে হবে এবং এই ক্ষমতা কোনো অবস্থাতেই বেসরকারি খাতে হস্তান্তর বা অর্পণ করা যাবে না।"},{"type":"clause","label":"১.৮","text":"এমতাবস্থায় ঔষধের প্রাপ্যতা নিশ্চিত করার লক্ষ্যে একটি স্বচ্ছ ও যৌক্তিক মূল্য নির্ধারণ পদ্ধতি প্রতিষ্ঠা করা জরুরী হয়ে উঠেছে। এ প্রসঙ্গে উল্লেখ্য যে, ২০২৩ সালে ‘ওষধ নিয়ন্ত্রণ অধ্যাদেশ, ১৯৮২’ রহিত করে ‘ওষধ ও কসমেটিকস আইন, ২০২৩’ প্রণীত হয়। এই নতুন আইনে ঔষধের প্রাপ্যতা নিশ্চিতকরণে সরকার কর্তৃক মূল্য নির্ধারণের পরিধি বিস্তৃত করা হয়। ‘ওষধের মূল্য নির্ধারণ পদ্ধতি’ প্রণয়নের উদ্দেশ্যে গঠিত টাস্কফোর্স একটি বিশেষজ্ঞ সাবকমিটির মাধ্যমে বিজ্ঞান ও অর্থনীতি বিবেচনায় যেয়ে দীর্ঘমেয়াদী ও বিশ্ব কর্মকাণ্ড পরিচালনা করে। বাংলাদেশের ঔষধখাত, আর্থ-সামাজিক অবস্থা, জনস্বাস্থ্য বাস্তবাত বিবেচনা এবং সংশ্লিষ্ট অংশীজনদের সাথে আলোচনার ভিত্তিতে টাস্কফোর্স একটি বিজ্ঞানসম্মত ও কাঠামোবদ্ধ মূল্য নির্ধারণ পদ্ধতি সুপারিশ করেছে।"},{"type":"clause","label":"১.৯","text":"এমতাবস্থায়, ১৯৮২ সালের ঔষধ নীতির মূল চেতনা, ২০২৩ সালের ঔষধ ও কসমেটিকস আইনের উদ্দেশ্য, ২০২৫ সালে মহামান্য হাইকোর্ট বিভাগ কর্তৃক প্রদত্ত নির্দেশনা এবং ২০২৫ সালে গঠিত টাস্কফোর্স-এর প্রস্তাবনার সঙ্গে সামঞ্জস্য রেখে, ক্রয়ক্ষমতার আলোকে ঔষধের সহজলভ্যতা নিশ্চিতকরণের মাধ্যমে জনস্বাস্থ্য সুরক্ষকে অধিকতর কার্যকর, স্বচ্ছ, তথ্যভিত্তিক ও সুশৃঙ্খল করার লক্ষ্যে জনস্বার্থে ‘ওষধের মূল্য নির্ধারণ পদ্ধতি ২০২৬ (অ্যালোপ্যাথিক)’ প্রণয়ন করা হলো।"},{"type":"heading","text":"২. ঔষধের মূল্য নির্ধারণ পদ্ধতির কৌশলসমূহ"},{"type":"clause","label":"২.১","text":"বাংলাদেশ সরকারের যথাযথ কর্তৃপক্ষ (ওষধ প্রশাসন অধিদপ্তর) কর্তৃক অনুমোদিত সকল অ্যালোপ্যাথিক ঔষধ ‘ওষধ ও কসমেটিকস আইন, ২০২৩’ এর ৩০(১) ধারা অনুযায়ী তালিকাভুক্ত বলে গণ্য হবে।"},{"type":"clause","label":"২.২","text":"দেশে অনুমোদিত সকল অ্যালোপ্যাথিক ঔষধের জন্য এই গেজেটে বর্ণিত যে কোনো একটি মূল্য নির্ধারণ পদ্ধতি অনুসরণ করা বাধ্যতামূলক হবে। কার্যকর ব্যবস্থাপনা ও প্রয়োগের সুবিধার্থে সকল ঔষধকে তিনটি প্রধান শ্রেণিতে বিন্যস্ত করা হয়েছে: (ক) বর্তমানে অনুমোদনপ্রাপ্ত ঔষধ, (খ) ভবিষ্যতে অনুমোদন লাভকারী ঔষধ এবং (গ) সকল প্রকার বায়োলজিক্যাল ও ইমিউনোলজিক্যাল ঔষধ বিদ্যমান ঔষধসমূহকে ‘অত্যাবশ্যকীয়’ ও ‘অন্যান্য’ এই দুটি উপ-বিভাগে এবং ভবিষ্যতে অনুমোদন লাভকারী ঔষধসমূহকে ‘পেটেন্ট-বহির্ভুত’ ও ‘পেটেন্ট-ভুক্ত’ এই দুটি উপ-বিভাগে বিভক্ত করা হয়েছে।"},{"type":"clause","label":"২.৩","text":"বর্তমানে অনুমোদনপ্রাপ্ত ঔষধ:"},{"type":"clause","label":"২.৩.১","text":"অত্যাবশ্যকীয় ঔষধ: অত্যাবশ্যকীয় ঔষধসমূহের মূল্য সাধারণ মানুষের ক্রয়ক্ষমতার মধ্যে রাখার লক্ষ্যে বর্তমানে প্রচলিত দীর্ঘ সময় ধরে পরীক্ষিত মার্কআপ বজায় রাখা হয়েছে। উৎপাদন ব্যয়ের সাথে একটি যৌক্তিক মুনাফা নির্ধারণের ফলে অত্যাবশ্যকীয় ঔষধের দাম সহনীয় থাকবে এবং সাধারণ মানুষের জন্য প্রাপ্যতা নিশ্চিত হবে।"},{"type":"clause","label":"২.৩.২","text":"অন্যান্য ঔষধ: যেসব ঔষধের নাম ‘অত্যাবশ্যকীয় ঔষধের জাতীয় তালিকা’য় নেই, সেগুলোকে ‘অন্যান্য ঔষধ’ হিসেবে বিবেচনা করে সেগুলোর মূল্য বাজারের মধ্যক দামের (Median Price) ভিত্তিতে নির্ধারিত হবে। এই পদ্ধতির মূল উদ্দেশ্য হলো বিভিন্ন ব্র্যান্ড বা ট্রেড নামের একই ঔষধে দামের মধ্যে পার্থক্য কমিয়ে বাজারে একটি সুশৃঙ্খল পরিবেশ তৈরি করা।"},{"type":"clause","label":"২.৪","text":"ভবিষ্যতে অনুমোদন লাভকারী ঔষধ:"},{"type":"clause","label":"২.৪.১","text":"পেটেন্ট-বহির্ভুত ঔষধ: এক্ষেত্রে অত্যাবশ্যকীয় ঔষধের মূল্য নির্ধারণের সূত্র অনুসরণ করা হবে। তবে নতুন ঔষধ উৎপাদনে উৎসাহ বজায় রাখার লক্ষ্যে এই শ্রেণির ঔষধের ক্যাটাগরি-ভিত্তিক মার্ক-আপ (Markup) অত্যাবশ্যকীয় ঔষধের তুলনায় প্রনোদনাসূচক মার্কআপ রাখা হয়েছে।"},{"type":"clause","label":"২.৪.২","text":"পেটেন্ট-ভুক্ত ঔষধ: এ সকল ঔষধের ক্ষেত্রে আন্তর্জাতিক রেফারেন্স মূল্য (International Reference Price) পদ্ধতি অনুসরণ করা হবে।"},{"type":"clause","label":"২.৫","text":"বায়োলজিক্যাল ও ইমিউনেলজিক্যাল ঔষধ: দেশীয় ঔষধ শিল্পকে গবেষণায় বিনিয়োগ এবং উন্নত প্রযুক্তির ঔষধ উৎপাদনে উৎসাহিত করার লক্ষ্যে এই ক্যাটাগরির ঔষধের ক্ষেত্রে উৎপাদনকারী বা প্রস্তুতকারককে অধিকতর মুনাফা অর্জনের সুযোগ প্রদান করা হয়েছে।"},{"type":"clause","label":"২.৬","text":"ঔষধের সরবরাহ নিশ্চিতকরণ: অত্যাবশ্যকীয় এবং জীবনরক্ষাকারী ঔষধের নিয়মিত সরবরাহ নিশ্চিত করতে একটি বিশেষ প্রস্তাবনা দেয়া হয়েছে। সকল ঔষধ উৎপাদনকারী প্রতিষ্ঠানের জন্য একটি নির্দিষ্ট পরিমাণ অত্যাবশ্যকীয় ঔষধের উৎপাদন ও সরবরাহ বজায় রাখা বাধ্যতামূলক করা হয়েছে। এই ব্যবস্থার ফলে বাজারে অত্যাবশ্যকীয় এবং জীবনরক্ষাকারী ঔষধের সংকট তৈরির সম্ভাবনা দূর হয়েছে।"},{"type":"heading","text":"৩. ঔষধের মূল্য নির্ধারণ পদ্ধতি"},{"type":"subheading","text":"৩.১.১ অত্যাবশ্যকীয় ঔষধ — কস্ট-প্লাস বেঞ্চমার্কিং"},{"type":"paragraph","text":"‘অত্যাবশ্যকীয় ঔষধের জাতীয় তালিকা’য় অন্তর্ভুক্ত ঔষধের ক্ষেত্রে, ভ্যাট ও অন্যান্য কর ব্যতীত সর্বোচ্চ খুচরা মূল্য (MRP), বাংলাদেশ সরকার কর্তৃক মনোনীত কমিটি/উপযুক্ত কর্তৃপক্ষ কর্তৃক নিম্নোক্ত ‘কস্ট-প্লাস বেঞ্চমার্কিং’ সূত্র (Cost-Plus Benchmarking Formula) অনুযায়ী নির্ধারিত হবে।"},{"type":"paragraph","text":"বেঞ্চমার্ক মূল্যে প্যাকেজিং অন্তর্ভুক্তকরণের ব্যাখ্যা:"},{"type":"paragraph","text":"৩.১.১.৩ ক্যাটাগরী ভিত্তিক সূত্র"},{"type":"table","rows":[["ক্রম","ঔষধের ক্যাটাগরী","কাঁচামাল ও প্রাইমারি প্যাকেজিং ব্যয়","মার্কআপ","সেকেন্ডারি ও টারশিয়ারি প্যাকেজিং ব্যয় (δ)","সর্বোচ্চ খুচরা মূল্য (ভ্যাট ও অন্যান্য কর ব্যতীত)"],["ক","বাল্ক সাবস্ট্যান্স (পুনঃপ্যাকিং)","১০০","১.৫০","δ","১৫০ + δ"],["খ","ওরাল ও টপিকাল (অ্যান্টিবায়োটিক বাদে)","১০০","২.২৫","δ","২২৫ + δ"],["গ","ওরাল অ্যান্টিবায়োটিক","১০০","২.৩০","δ","২৩০ + δ"],["ঘ","হরমোন ও স্টেরয়েড","১০০","২.৮০","δ","২৮০ + δ"],["ঙ","স্টেরাইল প্রিপারেশন","১০০","৩.৪০","δ","৩৪০ + δ"]]},{"type":"paragraph","text":"দ্রষ্টব্য: δ = সেকেন্ডারি ও টারশিয়ারি প্যাকেজিং ব্যয়"},{"type":"paragraph","text":"৩.১.১.৪ বেঞ্চমার্কিং পদ্ধতি ও সমন্বয় প্রক্রিয়া"},{"type":"subheading","text":"৩.১.২ অন্যান্য ঔষধ — রেফারেন্স প্রাইসিং"},{"type":"paragraph","text":"অত্যাবশ্যকীয় তালিকায় উল্লেখ নেই কিন্তু বাজারে বিদ্যমান এমন সকল ঔষধকে অন্যান্য ঔষধ হিসেবে বিবেচনা করা হবে এবং সেগুলোর ক্ষেত্রে, সর্বোচ্চ খুচরা মূল্য (ভ্যাট ও অন্যান্য কর ব্যতীত) উৎপাদক/প্রস্তুতকারক কর্তৃক প্রস্তাবিত হবে। সরকার মনোনীত কমিটি/উপযুক্ত কর্তৃপক্ষ নিম্নোক্ত ‘বেঞ্চমার্কিং’ পদ্ধতি অনুসরণ করে সর্বোচ্চ খুচরা মূল্য অনুমোদন করবে:"},{"type":"subheading","text":"৩.২.১ পেটেন্ট-বহির্ভুত ঔষধ (নতুন জেনেরিক)"},{"type":"paragraph","text":"যে সকল ঔষধ (বায়োলজিক্যাল ও ইমিউনোলজিক্যাল ব্যতীত) সরকার মনোনীত কমিটি/উপযুক্ত কর্তৃপক্ষ/ঔষধ প্রশাসন অধিদপ্তর-এর নিকট আবেদনের সময় পেটেন্টমুক্ত বা পেটেন্টের আওতাবহির্ভুত থাকবে, তাদের ক্ষেত্রে এই নিয়ম প্রযোজ্য হবে। এ ধরনের ঔষধকে ‘নতুন জেনেরিক’ হিসেবে বিবেচনা করা হবে।"},{"type":"paragraph","text":"৩.২.১.১ ক্যাটাগরী ভিত্তিক সূত্র"},{"type":"table","rows":[["ক্রম","ঔষধের ক্যাটাগরী","কাঁচামাল ও প্রাইমারি প্যাকেজিং ব্যয় (বেস ১০০)","বিদ্যমান ঔষধের মার্কআপ","নতুন জেনেরিকের প্রণোদনসূচক মার্কআপ (৩৩% অতিরিক্ত)","সর্বোচ্চ খুচরা মূল্য (ভ্যাট ও অন্যান্য কর ব্যতীত)"],["ক","বাল্ক সাবস্ট্যান্স (পুনঃপ্যাকিং)","১০০","১.৫০","২.০০","২০০ + δ"],["খ","ওরাল ও টপিকাল (অ্যান্টিবায়োটিক বাদে)","১০০","২.২৫","২.৯৯","২৯৯ + δ"],["গ","ওরাল অ্যান্টিবায়োটিক","১০০","২.৩০","৩.০৬","৩০৬ + δ"],["ঘ","হরমোন ও স্টেরয়েড","১০০","২.৮০","৩.৭২","৩৭২ + δ"],["ঙ","স্টেরাইল প্রিপারেশন","১০০","৩.৪০","৪.৫২","৪৫২ + δ"]]},{"type":"paragraph","text":"দ্রষ্টব্য: δ = সেকেন্ডারি ও টারশিয়ারি প্যাকেজিং ব্যয়"},{"type":"paragraph","text":"৩.২.১.১ বেঞ্চমার্কিং পদ্ধতি ও সমন্বয় প্রক্রিয়া"},{"type":"subheading","text":"৩.২.২ – ৩.৫ অন্যান্য বিধান"},{"type":"heading","text":"৪. আন্তঃখাতীয় বিধান এবং সংস্কার"},{"type":"clause","label":"৪.১","text":"অত্যাবশ্যকীয় ঔষধের সঙ্গে অন্যান্য ঔষধের উৎপাদন হারের আন্তঃসম্পর্ক: অত্যাবশ্যকীয় ঔষধের নিরবচ্ছিন্ন সরবরাহ ও প্রাপ্যতা নিশ্চিত করার লক্ষ্যে, অন্যান্য ঔষধের উৎপাদন ও বিক্রয় সুবিধা গ্রহণকারী প্রস্তুতকারকের প্রত্যেককে তাদের মোট বার্ষিক বিক্রয়ের (Total Annual Sales) অন্তত ২৫ শতাংশ (আর্থিক মূল্যের) সমপরিমাণ অত্যাবশ্যকীয় ঔষধের বিক্রয়ের মাধ্যমে অর্জিত হওয়া নিশ্চিত করতে হবে। কোনো প্রস্তুতকারক বার্ষিক লক্ষ্যমাত্রার এই অনুপাত রক্ষায় ব্যর্থ হলে, নীতিমালার যথাযথ অনুর্বর্তিতা অর্জিত না হওয়া পর্যন্ত সরকার মনোনীত কমিটি/উপযুক্ত কর্তৃপক্ষ/ওষধ প্রশাসন অধিদপ্তর ওই প্রতিষ্ঠানের নতুন কোনো ঔষধের অনুমোদনের আবেদন বিবেচনা করবে না।"},{"type":"clause","label":"৪.২","text":"অত্যাবশ্যকীয় ঔষধের সাথে সংমিশ্রণ: ‘অত্যাবশ্যকীয় ঔষধের জাতীয় তালিকা’য় অন্তর্ভুক্ত সকল ঔষধের অনুমোদিত সকল ফরমুলেশন, মাত্রা (Strength) এবং অন্যান্য ঔষধের সাথে সংমিশ্রিত রূপ এর মূল্য নির্ধারণের ক্ষেত্রে ধারা ১-তে বর্ণিত ‘কস্ট-প্ল্লাস বেঞ্চমার্কিং’ পদ্ধতি অনুসরণ করা বাধ্যতামূলক হবে।"},{"type":"clause","label":"৪.৩","text":"সরকার কর্তৃক নির্ধারিত সকল জীবনরক্ষকারী ঔষধ (মূলত জরুরী সেবার সাথে সম্পর্কিত) এর মূল্য নির্ধারণের ক্ষেত্রে ধারা ১-তে বর্ণিত ‘কস্ট-প্ল্লাস বেঞ্চমার্কিং’ পদ্ধতি অনুসরণ করা হবে।"},{"type":"clause","label":"৪.৪","text":"সক্রিয় ঔষধি উপাদান (Active Pharmaceutical Ingredients) আমদানির ক্ষেত্রে অনাপত্তিপত্র: দেশীয় এপিআই উৎপাদন সক্ষমতা বিকাশের লক্ষ্যে, আমদানিকারকদের এপিআই আমদানির পূর্বে ঔষধ প্রশাসন অধিদপ্তর বা ক্ষমতাপ্রাপ্ত কর্তৃপক্ষ থেকে অনাপত্তিপত্র গ্রহণ করতে হবে। এই অনাপত্তিপত্র প্রাপ্তির জন্য আমদানির জন্য আগ্রহী প্রতিষ্ঠানকে নিম্নোক্ত শর্তসমূহের যেকোনো একটির প্রমাণসহ আবেদন করতে হবে: (ক) দেশে সংশ্লিষ্ট এপিআই উৎপাদিত হয় না; অথবা (খ) দেশে উৎপাদিত হয় তবে উৎপাদক সরবরাহে অপারগতা প্রকাশ করেছেন; অথবা (গ) দেশীয়ভাবে উৎপাদিত এপিআই-এর মূল্য আন্তর্জাতিক রেফারেন্স মূল্যের তুলনায় ২০ শতাংশের বেশি। আবেদন প্রাপ্তির পরবর্তী ৭ (সাত) কার্যদিবসের মধ্যে ঔষধ প্রশাসন অধিদপ্তর বা সংশ্লিষ্ট কর্তৃপক্ষকে এই অনাপত্তিপত্র প্রদানের প্রক্রিয়া সম্পন্ন করতে হবে।"},{"type":"clause","label":"৪.৫","text":"রিগ্রেসিভ মার্কআপ (Regressive Markup) ভিত্তিক মূল্য নির্ধারণ পদ্ধতিতে রূপান্তর: এই পদ্ধতি অনুমোদনের পরবর্তী ৫ (গাঁচ) বছরের মধ্যে অত্যাবশ্যকীয় ঔষধের মূল্য নির্ধারণে ‘রিগ্রেসিভ মার্কআপ’ (Regressive Markup) পদ্ধতি প্রবর্তন করা হবে। রিগ্রেসিভ মার্কআপ পদ্ধতির মূল বৈশিষ্ট্য হলো- উচ্চমূলের ঔষধের ক্ষেত্রে তুলনামূলক নিম্নতর মার্কআপ এবং স্বল্পমূল্যের ঔষধের ক্ষেত্রে অপেক্ষাকৃত উচ্চতর মার্কআপ এর মাধ্যমে উৎপাদক ও বিক্রেতা পর্যায়ের আগ্রহ যুক্তিসঙ্গতকরণ। এই রূপান্তর প্রক্রিয়াকে কার্যকর করতে বিদ্যমান ‘কস্ট-প্ল্লাস’ ফর্মুলা সংশোধন করা হবে, যেখানে কাঁচামাল ও প্যাকেজিং ব্যয়ের পাশাপাশি অন্যান্য যাচাইযোগ্য প্রত্যক্ষ ব্যয় উপাদানগুলো অন্তর্ভুক্ত করে মার্কআপ কাঠামো পুনর্গঠন করা হবে। এর প্রধান লক্ষ্য হলো অত্যাবশ্যকীয় ঔষধের প্রাপ্যতার পাশাপাশি উৎপাদক ও বিক্রেতাদের জন্য স্বচ্ছ প্রক্রিয়ায় যৌক্তিক ও ন্যায়সঙ্গত মুনাফা মার্জিন নিশ্চিত করা।"},{"type":"clause","label":"৪.৬","text":"প্রাতিষ্ঠানিক রূপান্তর ও সক্ষমতা বৃদ্ধি: প্রস্তাবিত মূল্য নির্ধারণ কাঠামোর সফল বাস্তবায়নে অনতিবিলম্বে ঔষধ প্রশাসন অধিদপ্তরের অধীনে একটি স্বতন্ত্র ইউনিট গঠন করতে হবে, যা মূল্য নির্ধারণ কমিটিকে মূল্য বেঞ্চমার্কিং, তদারকি এবং প্রয়োজনীয় কারিগরি ও প্রশাসনিক সহায়তা প্রদান করবে। আগামী ৫ বছরের মধ্যে একটি স্বাধীন ‘বিধিবন্ধ কর্তৃপক্ষ’ (Statutory Authority) প্রতিষ্ঠার উদ্যেগ গ্রহন করতে হবে। উপযুক্ত আইনের মাধ্যমে গঠিত এই কর্তৃপক্ষ নিজস্ব প্রশাসনিক কাঠামো ও জবাবদিহি ব্যবস্থার অধীনে ঔষধ প্রশাসন অধিদপ্তর থেকে স্বতন্ত্রভাবে ঔষধের মূল্য সংক্রান্ত যাবতীয় কার্যক্রম তদারকি করবে।"},{"type":"paragraph","text":"জনস্বার্থে জারিকৃত এ প্রজ্ঞাপনটি অবিলম্বে কার্যকর হবে।"},{"type":"paragraph","text":"রাষ্ট্রপতির আদেশক্রমে\nমো. কায়ছার রহমান\nউপসচিব।"}],"taskforce":[{"type":"heading","text":"সংযুক্তি-১: টাস্কফোর্স"},{"type":"paragraph","text":"গণপ্রজাতন্ত্রী বাংলাদেশ সরকার · স্বাস্থ্য ও পরিবার কল্যাণ মন্ত্রণালয় · স্বাস্থ্য সেবা বিভাগ · ঔষধ প্রশাসন-১ শাখা · বাংলাদেশ সচিবালয়, ঢাকা · www.hsd.gov.bd"},{"type":"paragraph","text":"নম্বর: ৪৫.০০.০০০০.১৮২.০৬.০০২.২১.১৪৯ · তারিখ: ০৯ শ্রাবণ ১৪৩২ / ২৪ জুলাই ২০২৫"},{"type":"paragraph","text":"অত্যাবশ্যকীয় ওষধের জাতীয় তালিকা (National List of Essential Medicines) প্রণয়ন এবং প্রাপ্যতা নিশ্চিতকরণের লক্ষ্যে করণীয় বিষয়ে সুপারিশ প্রণয়নের উদ্দেশ্যে নিম্নরূপভাবে টাস্কফোর্স গঠন করা হলো।"},{"type":"table","rows":[["০১.","অধ্যাপক শাহিনুল আলম, উপাচার্য, বাংলাদেশ মেডিক্যাল বিশ্ববিদ্যালয়","সভাপতি"],["০২.","অধ্যাপক সোহেল মাহমুদ আরাফত, ইন্টারনাল মেডিসিন বিভাগ, বাংলাদেশ মেডিক্যাল বিশ্ববিদ্যালয়","সদস্য"],["০৩.","অধ্যাপক সৈয়দ আবদুল হামিদ, অধ্যাপক, স্বাস্থ্য অর্থনীতি বিভাগ, ঢাকা বিশ্ববিদ্যালয়","সদস্য"],["০৪.","অধ্যাপক জাকির আহমেদ চৌধুরী, চেয়ারম্যান, ফার্মেসী বিভাগ, ঢাকা বিশ্ববিদ্যালয়","সদস্য"],["০৫.","ডা. শারিমন আকাসী, সহযোগী অধ্যাপক, অবসটেক্সিল্ল এত গাইনোকোলজী বিভাগ, আনোয়ার খান মভান্ন মেডিক্যাল কলেজ","সদস্য"],["০৬.","ডা. শফিউল আলম চৌধুরী, সহযোগী অধ্যাপক, শিশু বিভাগ, ঢাকা মেডিক্যাল কলেজ","সদস্য"],["০৭.","ডা. শর্মিলা হুদা, সহযোগী অধ্যাপক, ফার্মাকোলজী এত খেরাপিউটিক্স বিভাগ, বাংলাদেশ মেডিক্যাল কলেজ","সদস্য"],["০৮.","ডা. ফারজানা রহমান, সহযোগী অধ্যাপক, কমিউনিটি সাইকিয়াট্রি বিভাগ, জাতীয় মানসিক স্বাস্থ্য ইন্স্টিটিউট","সদস্য"],["০৯.","ডা. আসমা সিদ্দিকা, সহযোগী অধ্যাপক, রেডিওথেরাপী বিভাগ, জাতীয় ক্যান্সার গবেষণা ইন্স্টিটিউট ও হাসপাতাল","সদস্য"],["১০.","ড. আহমেদ এহসানুর রহমান, সাইন্টিস্ট, আইসিডিডিআর, বি","সদস্য"],["১১.","ডা. মহিউদ্দিন আল হেলাল, সিনিয়র সহকারী সচিব (বিশ্ব স্বাস্থ্য-২ শাখা), স্বাস্থ্য সেবা বিভাগ","সদস্য"],["১২.","বিশ্ব স্বাস্থ্য সংস্থা এর উপযুক্ত প্রতিনিধি, (অত্যাবশ্যকীয় ওষধ সংক্রান্ত বিষয়ে বিশেষজ্ঞ)","সদস্য"],["১৩.","ইউনিসেফ এর উপযুক্ত প্রতিনিধি, (অত্যাবশ্যকীয় ওষধ সংক্রান্ত বিষয়ে বিশেষজ্ঞ)","সদস্য"],["১৪.","মহাপরিচালক (স্বাস্থ্য অধিদপ্তর) এর উপযুক্ত প্রতিনিধি, (অত্যাবশ্যকীয় ওষধ সংক্রান্ত বিষয়ে বিশেষজ্ঞ)","সদস্য"],["১৫.","মহাপরিচালক (ওষধ প্রশাসন অধিদপ্তর) এর উপযুক্ত প্রতিনিধি, (অত্যাবশ্যকীয় ওষধ সংক্রান্ত বিষয়ে বিশেষজ্ঞ)","সদস্য"],["১৬.","মহাপরিচালক (পরিবার পরিকল্পনা অধিদপ্তর) এর উপযুক্ত প্রতিনিধি, (অত্যাবশ্যকীয় ওষধ সংক্রান্ত বিষয়ে বিশেষজ্ঞ)","সদস্য"],["১৭.","মহাপরিচালক (স্বাস্থ্য অর্থনীতি ইউনিট) এর উপযুক্ত প্রতিনিধি, (অত্যাবশ্যকীয় ওষধ সংক্রান্ত বিষয়ে বিশেষজ্ঞ)","সদস্য"],["১৮.","জনাব মুহাম্মদ মোজাম্মেল হোসেন খান, যুগ্মসচিব (ওষধ প্রশাসন অনুবিভাগ), স্বাস্থ্য সেবা বিভাগ","সদস্য সচিব"]]},{"type":"subheading","text":"কার্যপরিধি"},{"type":"clause","label":"(ক)","text":"দেশের রোগের ধরণ, প্রকৃতি ও প্রবণতার উপর নির্ভর করে বিশ্ব স্বাস্থ্য সংস্থার এতদসংক্রান্ত সুপারিশের আলোকে কার্যকারিতা, নিরাপত্তা ও প্রয়োজনীয়তা বিবেচনা করে জাতীয় অত্যাবশ্যকীয় ওষধের তালিকা প্রণয়ন করা;"},{"type":"clause","label":"(খ)","text":"অত্যাবশ্যকীয় ওষধের প্রাপ্যতা ও সহজলভ্যতা নিশ্চিতকরণের লক্ষে এধরণের ওষধের মূল্য যৌক্তিকভাবে নির্বুপণ ও নির্মারণের জন্য Regulated Mark-Up Pricing ও অথবা Cost-Plus Pricing এর মতো স্বীকৃত নীতিমালার আলোকে অত্যাবশ্যকীয় ওষধসমুহের বিভিন্ন ফরমুলেশনের জন্য সহজে প্রয়োগযোগ্য বিশদ কর্মপদ্ধতি বা ফর্মুলা প্রণয়ন করা;"},{"type":"clause","label":"(গ)","text":"অন্যান্য ওষধের মূল্য নির্বুপণ ও নির্ধারণের জন্য Reference Pricing (External and Internal) অথবা অন্য কোন স্বীকৃত ও প্রচলিত পদ্ধতিতে বাংলাদেশের জনগণের সামর্থ্য বিবেচনা করে এবং ওষধ শিল্পের জন্যে যৌক্তিক ও ন্যায়াসঙ্গত মুনাফার সুযোগ রেখে এক বা একাধিক বিজানসম্মত পদ্ধতি নির্বাচন ও সেগুলোর কার্যকরভাবে প্রয়োগের লক্ষ্যে বিশদ কর্মপদ্ধতি বা ফর্মুলা প্রণয়ন করা; এবং"},{"type":"clause","label":"(ঘ)","text":"টাঙ্কফোর্স প্রয়োজনে উপযুক্ত বিশেষজ্ঞ প্রতিনিধি কো-অপ্ট করবে পারবে।"},{"type":"paragraph","text":"সময়সীমা: টাস্কফোর্স আগামী ২০ আগস্ট ২০২৫ খ্রি. এর মধ্যে এ সংক্রান্ত প্রতিবেদন মন্ত্রণালয়ে দাখিল করবেন।"},{"type":"paragraph","text":"০২। যথাযথ কর্তৃপক্ষের অনুমোদনক্রমে জনস্বার্থে জারিকৃত এ আদেশ অবিলম্বে কার্যকর হবে।"},{"type":"paragraph","text":"রাষ্ট্রপতির আদেশক্রমে,\n২৪-০৭-২০২৫\nমোহাম্মদ মোস্তাফিজুর রহমান\nসিনিয়র সহকারী সচিব\nফোন: ৫৫১০০৪৪২ (অফিস) · drugad1@hsd.gov.bd"},{"type":"heading","text":"মূল্য নির্ধারণ সাব কমিটি"},{"type":"paragraph","text":"স্মারক নং- ৪৫.০০.০০০০,১৮২.৯৯.০০২.২০(অংশ-১).২১৫ · তারিখ: ১৩ আশ্বিন ১৪৩২ / ২৮ সেপ্টেম্বর ২০২৫"},{"type":"paragraph","text":"গত ২১/০৯/২০২৫ তারিখে অনুষ্ঠিত অত্যাবশ্যকীয় ঔষধের জাতীয় তালিকা (National List of Essential Medicines) প্রণয়ন ও প্রাপ্যতা নিশ্চিতকরণের লক্ষ্যে গঠিত টাস্কফোর্স সভার সিদ্ধান্তের আলোকে ঔষধের মূল্য নির্ধারণের জন্য একটি সাব কমিটি নির্দেশক্রমে গঠন করা হলো:"},{"type":"table","rows":[["১.","অধ্যাপক সৈয়দ আব্দুল হামিদ, অধ্যাপক, স্বাস্থ্য অর্থনীতি বিভাগ, ঢাকা বিশ্ববিদ্যালয়","আহবায়ক"],["২.","উপসচিব, ঔষধ প্রশাসন-১ শাখা, স্বাস্থ্য সেবা বিভাগ","সদস্য"],["৩.","জনাব মোঃ আসরাফ হোসেন, পরিচালক, ঔষধ প্রশাসন অধিদপ্তর, ঢাকা।","সদস্য"],["৪.","অধ্যাপক জাকির আহমেদ চৌধুরী, চেয়ারম্যান, ফার্মেসি বিভাগ, ঢাকা বিশ্ববিদ্যালয়।","সদস্য"],["৫.","প্রতিনিধি, বিশ্বস্বাস্থ্য সংস্থা","সদস্য"],["৬.","ডা. মহিউদ্দিন আল হেলাল, সিনিয়র সহকারী সচিব, বিশ্বস্বাস্থ্য-২ শাখা, স্বাস্থ্য সেবা বিভাগ","সদস্য"],["৭.","ডা. দেওয়ান মোঃ ইমদাদুল হক, হেলথ ম্যানেজার, এমএনসিএইচ, ইউনিসেফ, বাংলাদেশ।","সদস্য"],["৮.","ডা. আহমেদ এহসানুর রহমান, সায়েক্সিস্ট, icddrb","সদস্য-সচিব"]]},{"type":"subheading","text":"কমিটির কার্যপরিধি"},{"type":"clause","label":"(ক)","text":"অত্যাবশ্যকীয় ঔষধের প্রাপ্যতা ও সহজলভ্যতা নিশ্চিতকরণের লক্ষ্যে এধরণের ঔষধের মূল্য যৌক্তিকভাবে নিরুপণ ও নির্ধারণের জন্য Regulated Mark-Up Pricing অথবা Cost-Plus Pricing এর মতো স্বীকৃত নীতিমালার আলোকে অত্যাবশ্যকীয় ঔষধসমূহের বিভিন্ন ফরমুলেশনের জন্য সহজে প্রয়োগযোগ্য বিশদ কর্মপদ্ধতি বা ফর্মুলা প্রণয়ন করা;"},{"type":"clause","label":"(খ)","text":"অন্যান্য ঔষধের মূল্য নিরুপণ ও নির্ধারণের জন্য Reference Pricing (External and Internal) অথবা তন্য কোন স্বীকৃত ও প্রচলিত পদ্ধতিতে বাংলাদেশের জনগণের সামর্থ্য বিবেচনা করে এবং ঔষধ শিল্পের জন্যে যৌক্তিক ও ন্যায়সঙ্গত মুনাফার সুযোগ রেখে এক বা একাধিক বিজ্ঞানসম্মত পদ্ধতি নির্বাচন ও সেগুলোর কার্যকরভাবে প্রয়োগের লক্ষ্যে বিশদ কর্মপদ্ধতি বা ফর্মুলা প্রণয়ন করা।"},{"type":"clause","label":"(গ)","text":"কমিটি প্রয়োজনে এক বা একাধিক সদস্য কো-অপ্ট করতে পারবে।"},{"type":"paragraph","text":"মো. কায়ছার রহমান\nউপসচিব\nফোন: ০১৭১৫-৯৩৭৯০৭ · drugad1@hsd.gov.bd"}]}}